tyrosine has been researched along with Malignant Melanoma in 270 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 141 (52.22) | 18.7374 |
1990's | 47 (17.41) | 18.2507 |
2000's | 51 (18.89) | 29.6817 |
2010's | 19 (7.04) | 24.3611 |
2020's | 12 (4.44) | 2.80 |
Authors | Studies |
---|---|
Almeida, J; Cabral, G; Francisco, AP; Mendes, E; Monteiro, AS; Nunes, R; Pereira, JD; Perry, MJ; Severino, P; Sousa, A; Videira, PA | 1 |
Calado, S; Francisco, AP; Gaspar, MM; Mendes, E; Pereira, JD; Perry, MJ; Santos, F; Sousa, A | 1 |
Bocik, W; Boja, E; Bowers, K; Carr, SA; Cocco, AR; Colantonio, S; Fang, B; Hiltke, T; Hoffman, MA; Holderfield, M; Kennedy, JJ; Koomen, JM; Kuhn, E; Lin, C; McCormick, F; Paulovich, AG; Roberts, R; Rodriguez, H; Schoenherr, RM; Sharma, K; Voytovich, U; Whiteaker, JR; Whiteley, G; Zhao, L | 1 |
Abrantes, JLF; Barreto Fonseca, EM; Clerici, SP; Cordeiro, HG; Ferreira-Halder, CV; Gonçalves, PR; Maria-Engler, SS; Massaro, RR; Milani, R; Rocha-Brito, KJP; Scotá Ferreira, AP | 1 |
Bodnár, A; Csomós, I; Filep, C; Kovács, T; Mátyus, L; Nagy, P; Nizsalóczki, E; Rebenku, I; Vámosi, G | 1 |
Baugher, C; Elnitski, L; Fedkenheuer, K; Fedkenheuer, M; Gotea, V; Holland, DO; Jaiswal, SK; Tan, H | 1 |
Gao, F; Guo, J; Li, X; Wang, L; Zhang, F; Zhao, R | 1 |
Alver, TN; Bøe, SL; Heintz, KM; Hovig, E | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Abdulla, DSY; Baues, C; Ceccon, G; Celik, E; Fink, GR; Galldiks, N; Hüllner, M; Kocher, M; Kreuzberg, N; Landsberg, J; Langen, KJ; Lohmann, P; Marnitz, S; Mauch, C; Ruge, MI; Scheffler, M; Schlaak, M; Schweinsberg, V; Stoffels, G; Tonn, JC; Trommer, M; Weller, M; Werner, JM; Wolf, J; Wolpert, F | 1 |
Campo, VE; Cecchini, AL; Cecchini, R; Cela, EM; González-Maglio, DH; Marinello, PC; Melo, GP; Ramalho, LZN; Souza-Neto, FP | 1 |
Cardoso, R; da S Gonçalves Vianez, JL; de Molfetta, FA; Nahum Alves, C; Santana da Costa, K; Souza da Costa, CH; Valente, R | 1 |
Arndt, S; Boskovic, M; Bosserhoff, AK; Dettmer, K; Fadil, F; Gronwald, W; Gruber, M; Karrer, S; Samol, C; Unger, P; Zimmermann, JL | 1 |
Fan, YF; Ge, GB; Hou, FB; Pan, QS; Qian, XK; Wang, P; Xiang, YW; Zhao, DF; Zhu, SX | 1 |
Behrendt, N; Böttcher, RT; Gaonkar, KS; Heim, JB; Krendel, M; Lee, JH; Lock-Andersen, J; Meves, A; Neu, A; Nikolova, E; Ordog, T; Sarkaria, JN; Saunte, DM; Sominidi-Damodaran, S; Sprangers, R; Squirewell, EJ; Stehle, T; van Deursen, J; Wyles, SP; Yan, H; Zocher, G | 1 |
Jho, EH; Jung, H; Kim, JY; Kim, K; Lim, KM; Oh, ES; Park, J | 1 |
Lauffenburger, D; Shao, H; Wang, A; Wells, A | 1 |
Corti, A; Curnis, F; Ghitti, M; Gori, A; Musco, G; Nardelli, F; Paissoni, C; Quilici, G; Sacchi, A; Traversari, C; Valentinis, B | 1 |
Cichewicz, RH; Du, L; King, JB; Miller, AN; Mooberry, SL; Powell, DR; Robles, AJ | 1 |
Ariizumi, K; Chung, JS; Cruz, PD; Tamura, K | 1 |
Bernardes, SS; Cecchini, AL; Cecchini, R; da Silva, CF; de Souza-Neto, FP; Derossi, DR; Guarnier, FA; Melo, GP; Ramalho, LN; Simão, AN | 1 |
Aigner, A; Appelhans, D; Burkhardt, J; Ewe, A; Janke, A; Przybylski, S | 1 |
Haapasaari, KM; Hintsala, HR; Jokinen, E; Karihtala, P; Koivunen, J; Moza, M; Ristimäki, A; Soini, Y | 1 |
Cárdenas, A; Contreras, P; Cooper-White, J; Díaz, J; Díaz, MI; Díaz, N; Leyton, L; Lobos-Gonzalez, L; Ortiz, R; Otte, E; Quest, AF; Torres, V | 1 |
Bundschuh, RA; Galldiks, N; Glas, M; Hattingen, E; Herrlinger, U; Kebir, S; Landsberg, J; Langen, KJ; Rauschenbach, L; Scheffler, B; Schlaak, M | 1 |
FITZPATRICK, TB; LERNER, AB | 1 |
JONES, HB; REID, JC | 1 |
Slominski, A; Slominski, R; Zbytek, B | 1 |
Fricke, AF; Gareiss, PC; Jacobs, SE; McNaughton, BR; Miller, BL; Scott, GA | 1 |
Adám, A; Barna, G; Berta, J; Cseh, S; Dobos, J; Döme, B; Flachner, B; Kenessey, I; Kéri, G; Keszthelyi, M; Klepetko, W; Krámer, Z; Mildner, M; Orfi, L; Szokol, B; Tímár, J; Tóvári, J | 1 |
Houlden, H; Paisán-Ruiz, C | 1 |
Pawelek, J; Slominski, A; Zmijewski, MA | 1 |
Dusseault, J; Ismaïl, S; Labelle-Côté, M; Larose, L; Picard-Cloutier, A; Siegel, PM | 1 |
Andersen, JH; Engh, RA; Genevière, AM; Hansen, E; Hanssen, KØ; Stiberg, T; Svenson, J | 1 |
Arvin, AM; Blau, HM; Brady, JJ; Oliver, SL; Reichelt, M; Sommer, MH; Sung, P | 1 |
Arstrand, K; Johansson, M; Kågedal, B; Lenner, L; Takasaki, A | 1 |
Bousquet, B; Garnier, JP; Ghanem, G; Le Bricon, T; Letellier, S; Morel, P; Stoitchkov, K; Tsankov, N | 2 |
Kanda, N; Watanabe, S | 1 |
Aglianò, AM; Calvieri, S; Chiummariello, S; Cigna, E; Frati, L; Gradilone, A; Haliassos, N; Massa, R; Ribuffo, D; Scuderi, N; Silvestri, I; Vonella, M | 1 |
Dong, J; Ivanov, VN; Krasilnikov, M; Ronai, Z | 1 |
Ito, S; Kageshita, T; Naito, A; Wakamatsu, K; Yokochi, M | 1 |
Arstrand, K; Ito, S; Kågedal, B; Nezirević, D; Takasaki, A; Wakamatsu, K | 1 |
Asawa, T; Huang, J; Sakai, R; Takato, T | 1 |
CURRIE, JW; GRIFFIN, AC; NEU, EE; ROBERTSON, CH; RUSSELL, WO | 1 |
BEELER, MF; HENRY, JB | 1 |
DOWD, GA; FIMIAN, WJ | 1 |
BOYLEN, JB; QUASTEL, JH | 1 |
DUCHON, J; GREGORA, V | 1 |
DUCHON, J | 1 |
ERB, W; HEMPEL, K | 1 |
SCOLARI, EG | 1 |
HARANGHY, L; KOVATS, Z | 1 |
HIRSCH, HM; ZELICKSON, AS | 1 |
HARTMANN, JF; HIRSCH, HM; ZELICKSON, AS | 1 |
DUCHON, J; PECHAN, Z | 1 |
HERZBERG, JJ | 1 |
GORIUKHINA, TA; IVANOV, II; PARSHIN, AN; SHERSTNEV, AE; SOLOV'EV, AL | 1 |
Hasegawa, K; Inoue, S; Ito, S; Olivares, C; Otake, H; Solano, F; Wakamatsu, K; Yukitake, J | 1 |
Chang, TM; Yu, B | 2 |
Altomonte, M; Calabro, L; Fonsatti, E; Leonardi, A; Maio, M; Pucillo, C; Tecce, R; Visintin, A | 1 |
Bannink, M; Eggermont, AM; Fekkes, D; Kruit, WH; Mulder, PG; Stoter, G; Van Gool, AR; van Ojik, HH | 1 |
All-Ericsson, C; Brodin, B; Girnita, L; Larsson, O; Müller-Brunotte, A; Ostman, A; Seregard, S | 1 |
Jimbow, K; Jin, HY; Kondo, S; Yamashita, T; Yoneta, A | 1 |
Bamberger, AM; Brümmer, J; Ebrahimnejad, A; Horst, AK; Nollau, P; Streichert, T; Wagener, C | 1 |
Barnd, DL; Bissonette, EA; Chianese-Bullock, KA; Deacon, DH; Grosh, WW; Hibbitts, S; Merrill, P; Neese, PY; Parekh, J; Patterson, JW; Petroni, GR; Slingluff, CL; Wiernasz, CJ; Woodson, EM; Yamshchikov, GV | 1 |
Engelhard, VH; Ostankovitch, M; Robila, V | 1 |
Bauer, UM; Behrmann, I; Haan, S; Heinrich, PC; Komyod, W | 1 |
Liu, H; Meadows, GG; Núñez, NP | 1 |
Chen, N; Qi, J; Siu, CH; Wang, J | 1 |
Furukawa, K; Hamamura, K; Hattori, H; Hattori, T; Hayashi, T; Lloyd, KO; Mizutani, H; Nakano, J; Nakashima, H; Okuda, T; Ueda, M; Urano, T | 1 |
Gilmore, J; Meredith, P; Nighswander-Rempel, SP; Riesz, J | 1 |
Qi, J; Romanyuk, O; Siu, CH; Wang, J | 1 |
Gruman, LM; Hendrix, MJ; Hess, AR; Kinch, MS; Seftor, EA; Seftor, RE | 1 |
Aixinjueluo, W; Furukawa, K; Hamamura, K | 1 |
Baccard, M; Basset-Seguin, N; Bousquet, B; Cassinat, B; Dubertret, L; Garnier, JP; Kerob, D; Le Bricon, T; Lebbé, C; Letellier, S; Morel, P; Stoitchkov, K | 1 |
Fang, CX; Huang, KJ; Ma, M; Ni, WZ; Yang, Q; Zhang, JX; Zhang, XL; Zheng, CY | 1 |
Critchley-Thorne, RJ; Holmes, SP; Lee, PP; Nacu, S; Weber, J; Yan, N | 1 |
Argov, S; Cagnano, E; Hammody, Z; Mordechai, S; Moreh, R; Sahu, RK | 1 |
Ekmekcioglu, S; Ellerhorst, J; Grimm, EA; Tang, CH | 1 |
Coward, RF; Middleton, JE; Smith, P | 1 |
Bomirski, A; Dernalowicz, E; Dominiczak, T; Trojanowski, J | 1 |
Cooper, M; Mishima, Y | 1 |
Hakim, AA | 1 |
Albert, D; Chen, AP; de Noronha, F; Essex, M; Kelliher, M; Niederkorn, JY; Shadduck, JA | 1 |
Ali, FM; Barnes, DA; Black, ML; Camp, VM; Faraj, BA; Lawson, DH; Nixon, DW; Richmond, A; Tindall, GT | 1 |
Chen, AP; de Noronha, F; Essex, M | 1 |
Jergil, B; Lindbladh, C; Rorsman, H; Rosengren, E | 3 |
Fujita, K; Ito, S; Jimbow, K; Kato, T; Kiyota, M | 1 |
Blair, H; Okun, MR; Schley, L; Ziegelstein, R | 1 |
Goldhirsch, A; Zava, DT | 1 |
Scisłowski, PW; Słominski, A | 1 |
DiSorbo, DM; Harris, NA; Nathanson, L | 1 |
Saga, K; Shimojo, T | 2 |
Blagoeva, PM | 1 |
Farishian, RA; Whittaker, JR | 3 |
Ekel, TM; Hearing, VJ; Montague, PM; Nicholson, JM | 1 |
Lubahn, DB; McCarty, KS; Seigler, HF; Stowers, S; Wortman, J | 1 |
Klein, LE; Nordlund, JJ | 1 |
Ichihashi, M; Mishima, Y; Mojamdar, M | 1 |
Körner, A; Pawelek, J | 1 |
Meadows, GG; Pierson, HF | 2 |
Bornstein, P; Casnellie, JE; Gallis, B; Krebs, EG; Marquardt, H; Pike, LJ; Todaro, GJ | 1 |
Abdallah, RM; Desai, PR; Meadows, GG; Pierson, HF | 1 |
Bowers, RR; Hadfield, TL; Shieh, SJ | 1 |
Wick, MM | 1 |
Devenish, RJ; Grubb, D; Hatzinisiriou, I; Linnane, AW; Payne, MJ; Ralph, SJ; Wines, BD | 1 |
Barlati, S; Bona, C; De Petro, G; Paracini, F; Tonelli, M | 1 |
Liang, H; Scott, G | 1 |
Richmond, A; Schraw, W | 1 |
Carstam, R; Hindemith, A; Odh, G; Paulson, J; Rorsman, H; Rosengren, E | 1 |
Feinendegen, LE; Müller-Gärtner, HW; Papaspyrou, M | 1 |
Alena, F; Iwashina, T; Jimbow, K; Pankovich, J; Umemura, T; Yamada, K | 1 |
Guichard, M; Thomas, CD | 1 |
Chaitchik, S; Feldman, I; Fishman, P; Merimsky, O; Rapaport, Y; Shafir, R; Sheonfeld, Y | 1 |
Odh, G; Rorsman, H; Rosengren, E; Wittbjer, A | 1 |
Gomez, LA; Rieber, M; Strasberg Rieber, M | 1 |
Aimola, P; Amicarelli, F; Arcadi, A; Bonfigli, A; Miranda, M; Natali, PG; Poma, A; Porretta, R; Ragnelli, AM; Savino, M; Zarivi, O | 1 |
Amicarelli, F; Brisdelli, F; D'Alessandro, E; Ligas, C; Miranda, M; Poma, A; Zarivi, O | 1 |
Deutscher, SL; Glinsky, GV; Glinsky, VV; Peletskaya, EN; Quinn, TP | 1 |
Garbe, C; Lassmann, G; Pötsch, S; Wellnitz, U | 1 |
Bousquet, B; Garnier, JP; Letellier, S; Spy, J | 1 |
Coit, DG; Dickler, MN; Meyers, ML | 1 |
Devenish, RJ; Edmondson, S; Estcourt, MJ; Hatzinisiriou, I; Hersey, P; Krauer, KG; Ralph, SJ; Tam, ND; Wong, LH | 1 |
Chen, WT; Mueller, SC; Nakahara, H; Nomizu, M; Yamada, Y; Yeh, Y | 1 |
Falcone, DJ; Hajjar, DP; Hsu, HY; Khan, KM | 1 |
Darbon, JM; Malecaze, F; Manenti, S | 1 |
Burgaud, JL; Fehrentz, JA; Martinez, J; Nahon, JL; Poosti, R | 1 |
Fischer, P; Schartl, M; Wellbrock, C | 1 |
Jimbow, K | 1 |
Fischer, P; Friedrich, K; Geissinger, E; Gómez, A; Schartl, M; Wellbrock, C | 1 |
Fu, YM; Li, YQ; Meadows, GG | 1 |
Ceha, HM; Medema, RH; Nasser, I; Slebos, RJ | 1 |
Daniels, KJ; Hay, ED; Kim, K | 1 |
Ferrans, VJ; Fu, YM; Meadows, GG; Pelayo, BA; Yu, ZX | 1 |
Hoekstra, HJ; Kole, AC; Koops, HS; Molenaar, WM; Nieweg, OE; Pruim, J; Vaalburg, W; van Ginkel, RJ | 1 |
Baccard, M; Bousquet, B; Garnier, JP; Kerneis, Y; Le Bricon, T; Letellier, S; Revol, M; Spy, J; Stoitchkov, K | 1 |
Bianchini, S; Miranda, M; Poma, A | 1 |
Behrmann, I; Haan, S; Heinrich, PC; Kortylewski, M; Müller-Esterl, W; Schaper, F | 1 |
Gilchrest, BA; Park, HY | 1 |
Benathan, M; Furumura, M; Hearing, VJ; Kobayashi, N; Panizzon, RG; Virador, V | 1 |
Ahmed, B; Van Den Oord, JJ | 1 |
Han, J; Jenq, W; Kefalides, NA | 1 |
Baĭkova, VN; Chernova, NV; Dumbraĭs, KO; Gracheva, IV; Lebedev, VI; Leonidova, IuA; Moiseenko, EI; Zaeva, GE; Zakharova, NV | 1 |
Paku, S; Raz, A; Timár, J; Tóth, S; Tóvári, J | 1 |
Fu, YM; Meadows, GG; Pelayo, BA | 2 |
Maeda, H; Murai, T; Nakagawa, Y; Terada, K | 1 |
Buzaid, AC; Ekmekcioglu, S; Ellerhorst, J; Grimm, EA; Munsell, M; Prieto, VG; Smid, CM | 1 |
An, WG; Bonvini, P; Dunach, M; Garcia de Herreros, A; Neckers, LM; Nguyen, P; Rosolen, A; Trepel, J | 1 |
Bousquet, B; Garnier, JP; Le Bricon, T; Letellier, S; Morel, P; Naumova, E; Peytcheva, E; Stoitchkov, K; Toneva, M; Tzankov, N | 1 |
Carles-Kinch, K; Gardner, LM; Hendrix, MJ; Hess, AR; Kinch, MS; Schneider, GB; Seftor, EA; Seftor, RE | 1 |
Behrmann, I; Böhm, M; Funk, JO; Heinrich, PC; Kortylewski, M; Kues, T; Luger, TA; Raghunath, M; Schulte, U; Schwarz, T | 1 |
Bamberger, AM; Brümmer, J; Ebrahimnejad, A; Flayeh, R; Löning, T; Schumacher, U; Wagener, C | 1 |
Blystone, S; Ilić, D; Leong, SP; Li, X; Ramos, DM; Regezi, J; Ross, FP | 1 |
Ge, X; Meadows, GG; Zhang, H | 1 |
Darrah, D; Halpern, S; Jones, V; Kan-Mitchell, J; Mitchell, MS; Voland, J; Wallace, A; Yeung, D | 1 |
Alewood, PF; Boyd, AW; Down, M; Lackmann, M; Lawrenson, ID; Lock, P; Schoenwaelder, SM; Wimmer-Kleikamp, SH | 1 |
Campbell, IT; Harvie, MN; Howell, A; Thatcher, N | 1 |
Fu, YM; Ge, X; Li, YQ; Meadows, GG | 1 |
Lee, MS; Lee, TH | 2 |
Hu, F; White, R | 1 |
Agrup, G; Bengtsson, M; Falck, B; Persson, K; Rorsman, H; Rosengren, AM; Rosengren, E | 1 |
Agris, PF; Kovacs, SH; Lin, VK; Ortwerth, BJ; Rodi, C | 1 |
Hearing, VJ | 1 |
Pawelek, JM | 1 |
Benfield, JR; Makarski, JS; Niles, RM | 1 |
Jensen, OA | 1 |
Watson, PG | 1 |
Ekel, TM; Hearing, VJ; Montague, PM; Nicholson, JM; Tomecki, KJ | 1 |
Ekel, TM; Hearing, ED; Hearing, VJ; Montague, PM; Nicholson, JM | 1 |
Wirtschafter, JD | 1 |
Chavin, W; Chen, YM | 1 |
Cariglia, N; Edelstein, LM; Okun, MR; Patel, RP; Smucker, D | 1 |
Bomirski, A; Wrzolkowa, T | 1 |
Frei, E; Wick, MM | 1 |
Harrison, DF | 1 |
Collard, J; Cornain, S; de Vries, JE; Rümke, P; van Wingerden, I; Vennegoor, C | 1 |
Gerner, RE; Kitamura, H; Moore, GE | 1 |
DiGiovanni, J; Elmer, GW; Meadows, GG; Minor, L | 1 |
Boulton, T; Chan, A; Cobb, M; Faletto, D; Funasaka, Y; Halaban, R; Rosen, E; Rubin, JS; White, W; Yoko, K | 1 |
Harris, H; Winder, AJ | 1 |
D'Ischia, M; Hearing, VJ; Palumbo, A; Prota, G; Tsukamoto, K | 1 |
Fisher, GJ; Fligiel, SE; Inman, DR; Talwar, HS; Varani, J; Voorhees, JJ | 1 |
Jimbow, K; Pankovich, JM | 1 |
Arnold, W; Lassmanm, G; Liermann, B; Schwabe, K | 1 |
Costantino, R; Slominski, A | 1 |
Slominski, A | 1 |
d'Ischia, M; Iannone, A; Misuraca, G; Palumbo, A; Prota, G | 1 |
Bover, L; Guerra, L; Mordoh, J | 1 |
Abdallah, RM; Aslakson, CJ; Meadows, GG; Starkey, JR | 1 |
McEwan, M; Parsons, PG | 1 |
Bomirski, A; Kuklinska, E; Moellmann, G; Pawelek, J; Słominski, A | 1 |
Aime, S; Crippa, PR | 1 |
Abdallah, RM; Meadows, GG; Starkey, JR | 1 |
Acosta, PB; Bleier, JC; Heymsfield, SB; Lawson, DH; Nixon, DW; Stockton, LH | 1 |
Rorsman, H; Rosengren, AM; Rosengren, E | 1 |
Haberman, HF; Menon, IA | 4 |
Benyumovich, MS; Lerman, MI | 1 |
Edelstein, LM; Okun, MR; Patel, RP; Wilgram, GF; Yee, WA | 1 |
Miyazaki, K; Otaki, N | 1 |
Akiba, H; Kato, T; Nakano, H; Seiji, M | 1 |
Nakayasu, M; Oikawa, A | 1 |
Donnellan, B; Edelstein, LM; Okun, MR; Patel, RP | 2 |
Bienieki, TC; Holstein, TJ; Quevedo, WC; Stowell, CP; Zarcaro, RM | 1 |
Drewa, G; Zbytniewski, Z | 3 |
Murthy, VV; Pomerantz, SH | 1 |
Kleisbauer, JP; Profisi-Centa, G; Roubin, R | 1 |
Hu, F | 1 |
Morowitz, J; Pawelek, J; Sansone, M; Wong, G | 1 |
Donnellan, B; Edelstein, LE; Okun, MR; Pearson, SH | 1 |
Dipasquale, A; Lerner, AB; McGuire, JS; Pawelek, J; Varga, JM | 1 |
Edmund, J; Egeberg, J; Jensen, OA | 4 |
McGuire, J | 1 |
Swan, GA | 1 |
Oikawa, A | 1 |
Blois, MS | 1 |
Cariglia, N; Edelstein, LM; Okun, MR; Patel, RP | 1 |
Nakayasu, M; Nohara, M; Oikawa, A; Tchen, TT | 1 |
Hamada, T; Mishima, Y | 1 |
Lee, MS; Lee, TH; Lu, MY | 1 |
Demopoulos, HB; Zara, HD | 1 |
Käser, H | 1 |
DeWys, WD; Hall, TC | 1 |
Barth, RF; Dunn, DR | 1 |
Allegri, G; Bordin, F; Costa, C; De Antoni, A | 1 |
Hu, F; Kitano, Y | 2 |
Demopoulos, HB; Duke, PS; Yuen, TG | 1 |
Harris, EB; Kirchheimer, WF; Prabhakaran, K | 1 |
Mishima, Y; Satoh, GJ | 1 |
Edelstein, L; Hamada, G; Niebauer, G; Okun, MR | 1 |
Silagi, S | 1 |
Demopoulos, HB; Hourani, BT | 1 |
Deppisch, LM; Gang, H; Goldstein, M; Gumport, SL; Sohn, N | 1 |
Donnellan, B; Edelstein, LM; Hamada, G; Okun, MR; Or, N | 1 |
Van Woert, MH | 1 |
Korb, F; Prasad, KN; Van Woert, MH | 1 |
Herrmann, WP | 1 |
Prabhakaran, K | 1 |
Lerner, AB | 1 |
Pomerantz, SH | 2 |
Anton, AH; Greer, M; Williams, CM | 1 |
Fischer, RD; Schachtschabel, D; Zilliken, F | 1 |
Lintermans, J; Maillard, GF | 1 |
Moore, GE; Tritsch, GL; Ulrich, K | 1 |
Demopoulos, HB; Duke, PS; Mitamura, A; Yuen, T | 1 |
Demopoulos, HB | 2 |
Hempel, K; Männl, HF | 1 |
Conradi, G; Schwartze, G | 1 |
11 review(s) available for tyrosine and Malignant Melanoma
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Spectrophotometric Assays for Sensing Tyrosinase Activity and Their Applications.
Topics: Biosensing Techniques; Humans; Kinetics; Melanoma; Melanoma, Cutaneous Malignant; Monophenol Monooxygenase; Oxidation-Reduction; Skin Neoplasms; Spectrophotometry; Tyrosine | 2021 |
L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions.
Topics: Animals; Humans; Levodopa; Melanins; Melanocytes; Melanoma; Models, Biological; Monophenol Monooxygenase; Oxidative Stress; Skin Neoplasms; Structure-Activity Relationship; Tyrosine | 2012 |
Biosignals modulated by tumor-associated carbohydrate antigens: novel targets for cancer therapy.
Topics: Anoikis; Antibodies, Monoclonal; Carcinoma, Small Cell; Cell Line, Tumor; Cell Proliferation; Crk-Associated Substrate Protein; Focal Adhesion Protein-Tyrosine Kinases; Gangliosides; Glycosphingolipids; Humans; Lung Neoplasms; Melanoma; Neoplasm Invasiveness; Paxillin; Phosphorylation; Tyrosine | 2006 |
Adjuvant therapy of malignant melanoma.
Topics: Adjuvants, Immunologic; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Drug Approval; Female; Humans; Immunotherapy; Incidence; Interferon-alpha; Interferons; Levamisole; Lymphatic Metastasis; Male; Melanoma; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Tyrosine; United States; United States Food and Drug Administration; Vaccines | 1997 |
Signaling pathways mediating melanogenesis.
Topics: Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Humans; Melanins; Melanocytes; Melanoma; Melanoma, Experimental; Melanosomes; Mice; Monophenol Monooxygenase; Neoplasms, Radiation-Induced; Phosphorylation; Protein Kinase C; Protein Processing, Post-Translational; Signal Transduction; Skin Neoplasms; Skin Pigmentation; Tumor Cells, Cultured; Tyrosine; Ultraviolet Rays | 1999 |
Factors regulating growth and pigmentation of melanoma cells.
Topics: Animals; Bone Neoplasms; Bromodeoxyuridine; Catechol Oxidase; Cell Division; Cell Line; Cell Transformation, Neoplastic; Cricetinae; Cyclic AMP; Dihydroxyphenylalanine; Melanins; Melanocyte-Stimulating Hormones; Melanocytes; Melanoma; Mice; Neoplasms, Experimental; Oncogenic Viruses; Pigmentation; Tyrosine | 1976 |
The eye in alkaptonuria.
Topics: Alkaptonuria; Chemical Phenomena; Chemistry; Connective Tissue; Diagnosis, Differential; Diagnostic Errors; Eye Diseases; Eye Neoplasms; Female; Humans; Joint Diseases; Male; Melanoma; Ochronosis; Oxidation-Reduction; Pigmentation; Tyrosine | 1976 |
A revised concept of mammalian melanogenesis: the possible synergistic functions of aerobic dopa oxidase and peroxidase. A review.
Topics: Aerobiosis; Animals; Catechol Oxidase; Eosinophils; Histocytochemistry; Humans; Mast Cells; Melanins; Melanocytes; Melanoma; Mice; Monophenol Monooxygenase; Neutrophils; Peroxidases; Plants; Tyrosine | 1973 |
Structure, chemistry, and biosynthesis of the melanins.
Topics: Animals; Birds; Carbon Radioisotopes; Catechol Oxidase; Catechols; Chemical Phenomena; Chemistry; Dihydroxyphenylalanine; Dopamine; Electron Spin Resonance Spectroscopy; Eye; Feathers; Hair; Humans; Indoles; Liver; Magnetic Resonance Spectroscopy; Melanins; Melanoma; Mice; Oxidation-Reduction; Pyrroles; Rats; Spectrophotometry, Ultraviolet; Tyrosine; X-Ray Diffraction | 1974 |
[Biochemistry of cell differentiation--introduction].
Topics: Acetylcholinesterase; Bromodeoxyuridine; Catechol Oxidase; Cell Differentiation; Cells, Cultured; Cholinesterases; Melanins; Melanocytes; Melanoma; Neuroblastoma; Retina; Tyrosine; Tyrosine 3-Monooxygenase | 1972 |
5 trial(s) available for tyrosine and Malignant Melanoma
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Comparison of phaeomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients.
Topics: Adult; Aged; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Cysteinyldopa; Female; Humans; Male; Melanins; Melanoma; Middle Aged; Serum; Skin Neoplasms; Tyrosine | 2003 |
Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations.
Topics: Adult; Aged; Amino Acids; Biopterins; Drug Administration Schedule; Female; Humans; Hydroxyindoleacetic Acid; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Middle Aged; Neopterin; Phenylalanine; Pilot Projects; Polyethylene Glycols; Pteridines; Randomized Controlled Trials as Topic; Recombinant Proteins; Time Factors; Tryptophan; Tyrosine | 2004 |
Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule.
Topics: Adult; Aged; Antineoplastic Agents; Cancer Vaccines; Disease-Free Survival; Drug Administration Schedule; Female; gp100 Melanoma Antigen; HLA Antigens; Humans; Interleukin-2; Male; Melanoma; Membrane Glycoproteins; Middle Aged; Neoplasm Proteins; Skin Neoplasms; Treatment Outcome; Tyrosine; Vaccines, Subunit | 2004 |
Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope.
Topics: Animals; B7-1 Antigen; CD8-Positive T-Lymphocytes; Disease-Free Survival; Drosophila; Epitopes; HLA-A2 Antigen; Humans; Immunization; Immunotherapy, Adoptive; Infusions, Intravenous; Intercellular Adhesion Molecule-1; Melanoma; Skin Neoplasms; Transduction, Genetic; Treatment Outcome; Tyrosine | 2002 |
255 other study(ies) available for tyrosine and Malignant Melanoma
Article | Year |
---|---|
Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines.
Topics: Amino Acids; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Structure; Monophenol Monooxygenase; Prodrugs; Structure-Activity Relationship; Triazenes | 2013 |
The selective cytotoxicity of new triazene compounds to human melanoma cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dimerization; Drug Screening Assays, Antitumor; Half-Life; Humans; Melanoma; Mice; Triazenes | 2017 |
Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling.
Topics: Humans; Mass Spectrometry; Melanoma; Mitogen-Activated Protein Kinase Kinases; Proto-Oncogene Proteins c-akt; Receptor Protein-Tyrosine Kinases; Tyrosine | 2021 |
Quercetin increases mitochondrial proteins (VDAC and SDH) and downmodulates AXL and PIM-1 tyrosine kinase receptors in NRAS melanoma cells.
Topics: Apoptosis; GTP Phosphohydrolases; Humans; Melanoma; Membrane Proteins; Mitochondrial Proteins; Proto-Oncogene Proteins c-pim-1; Quercetin; Receptor Protein-Tyrosine Kinases; Succinate Dehydrogenase; Tyrosine | 2022 |
Opposing Effects of Chelidonine on Tyrosine and Serine Phosphorylation of STAT3 in Human Uveal Melanoma Cells.
Topics: Apoptosis; Benzophenanthridines; Berberine Alkaloids; Cell Line, Tumor; Humans; Interleukin-6; Melanoma; Microtubules; Phosphorylation; Serine; Signal Transduction; STAT3 Transcription Factor; Tyrosine; Uveal Neoplasms | 2021 |
Characterization and clustering of kinase isoform expression in metastatic melanoma.
Topics: Cell Line, Tumor; Cluster Analysis; Humans; Melanoma; Protein Isoforms; Proto-Oncogene Proteins B-raf; Tyrosine | 2022 |
Sequence-Dependent Tyrosine-Containing Peptide Nanoassemblies for Sensing Tyrosinase and Melanoma.
Topics: Humans; Melanins; Melanoma; Monophenol Monooxygenase; Peptides; Tyrosine | 2022 |
Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathway.
Topics: Drug Resistance, Neoplasm; Humans; Indoles; Melanoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins B-raf; Receptor Protein-Tyrosine Kinases; Sulfonamides; Tyrosine; Vemurafenib | 2023 |
Treatment Monitoring of Immunotherapy and Targeted Therapy Using
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Combined Modality Therapy; Disease Progression; Female; Humans; Immunotherapy; Lung Neoplasms; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Retrospective Studies; Treatment Outcome; Tyrosine | 2021 |
Metformin inhibits the inflammatory and oxidative stress response induced by skin UVB-irradiation and provides 4-hydroxy-2-nonenal and nitrotyrosine formation and p53 protein activation.
Topics: Aldehydes; Animals; Carcinogenesis; DNA Damage; Female; Humans; Melanoma; Metformin; Mice; Oxidative Stress; Radiation Injuries, Experimental; Radiodermatitis; Skin; Skin Neoplasms; Tumor Suppressor Protein p53; Tyrosine; Ultraviolet Rays | 2020 |
Analysis of Kojic Acid Derivatives as Competitive Inhibitors of Tyrosinase: A Molecular Modeling Approach.
Topics: Catalytic Domain; Enzyme Inhibitors; Humans; Levodopa; Melanins; Melanocytes; Melanoma; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Monophenol Monooxygenase; Pyrones; Skin Neoplasms; Structure-Activity Relationship; Tyrosine | 2021 |
Cold Atmospheric Plasma Changes the Amino Acid Composition of Solutions and Influences the Anti-Tumor Effect on Melanoma Cells.
Topics: Apoptosis; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p16; Humans; Melanocytes; Melanoma; Plasma Gases; Reactive Nitrogen Species; Reactive Oxygen Species; Tryptophan; Tyrosine | 2021 |
Myosin-1E interacts with FAK proline-rich region 1 to induce fibronectin-type matrix.
Topics: Animals; Embryo Loss; Extracellular Matrix; Female; Fibroblasts; Fibronectins; Focal Adhesion Kinase 1; Humans; Melanoma; Mesoderm; Mice, Mutant Strains; Myosin Type I; Myosins; Osteopontin; Phosphorylation; Pregnancy; Protein Domains; Skin Neoplasms; Tyrosine | 2017 |
D-tyrosine negatively regulates melanin synthesis by competitively inhibiting tyrosinase activity.
Topics: Cell Line, Tumor; Humans; Melanins; Melanocytes; Melanoma; Monophenol Monooxygenase; Neoplasm Proteins; Tyrosine; Ultraviolet Rays | 2018 |
Tyro3-mediated phosphorylation of ACTN4 at tyrosines is FAK-dependent and decreases susceptibility to cleavage by m-Calpain.
Topics: Actinin; Amino Acid Substitution; Calpain; Cell Line; Cell Line, Tumor; Cell Movement; Enzyme Activation; Focal Adhesion Kinase 1; Gene Knockdown Techniques; Green Fluorescent Proteins; Humans; Melanoma; Mutation; Neoplasm Invasiveness; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; Protein Stability; Proteolysis; Receptor Protein-Tyrosine Kinases; Recombinant Fusion Proteins; RNA Interference; Signal Transduction; Tyrosine | 2018 |
Succinimide-Based Conjugates Improve IsoDGR Cyclopeptide Affinity to α
Topics: Allosteric Regulation; Binding, Competitive; Cell Line, Tumor; Cell Membrane; HEK293 Cells; Humans; Integrin alphaVbeta3; Magnetic Resonance Spectroscopy; Melanoma; Molecular Docking Simulation; Peptides, Cyclic; Protein Conformation; Snake Venoms; Structure-Activity Relationship; Succinimides; Tyrosine | 2018 |
Crowdsourcing natural products discovery to access uncharted dimensions of fungal metabolite diversity.
Topics: Animals; Antineoplastic Agents; Biological Products; Cell Line, Tumor; Cell Survival; Coculture Techniques; Crystallography, X-Ray; Drug Evaluation, Preclinical; Fungi; Humans; Melanoma; Methionine; Mice; Molecular Conformation; Peptide Synthases; Polyketides; Pseudomonas; Shikimic Acid; Transplantation, Heterologous; Tyrosine | 2014 |
DC-HIL-expressing myelomonocytic cells are critical promoters of melanoma growth.
Topics: Adoptive Transfer; Amino Acid Motifs; Animals; CD11b Antigen; Cell Proliferation; Cytokines; Eye Proteins; Interferon-gamma; Interleukin-1beta; Lymphocyte Activation; Melanoma; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Neoplasm Transplantation; Phenotype; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Syndecan-4; T-Lymphocytes; Tyrosine | 2014 |
Systemic oxidative profile after tumor removal and the tumor microenvironment in melanoma patients.
Topics: Adult; Aged; Female; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Oxidative Stress; Skin Neoplasms; Tumor Microenvironment; Tyrosine; Young Adult | 2015 |
A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo.
Topics: Animals; Cell Line, Tumor; Gene Transfer Techniques; Humans; Inhibitor of Apoptosis Proteins; Melanoma; Mice, Nude; Molecular Weight; Polyethyleneimine; Repressor Proteins; RNA, Small Interfering; Survivin; Tyrosine | 2016 |
Nrf2/Keap1 Pathway and Expression of Oxidative Stress Lesions 8-hydroxy-2'-deoxyguanosine and Nitrotyrosine in Melanoma.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Cell Line, Tumor; Deoxyguanosine; Female; Humans; Intracellular Signaling Peptides and Proteins; Kaplan-Meier Estimate; Kelch-Like ECH-Associated Protein 1; Male; Melanoma; NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Proteins B-raf; Signal Transduction; Skin Neoplasms; Tyrosine | 2016 |
Extracellular matrix-specific Caveolin-1 phosphorylation on tyrosine 14 is linked to augmented melanoma metastasis but not tumorigenesis.
Topics: Animals; Carcinogenesis; Caveolin 1; Cell Adhesion; Cell Movement; Female; Fibroblasts; Fibronectins; Humans; Integrin beta1; Laminin; Lung Neoplasms; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Skin Neoplasms; Tyrosine | 2016 |
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases.
Topics: Brain Neoplasms; Humans; Melanoma; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2016 |
Enzymatic oxidation of tyrosine and dihydroxyphenylalanine by melanoma extracts.
Topics: Dihydroxyphenylalanine; Humans; Melanoma; Oxidation-Reduction; Tyrosine | 1948 |
Radioactivity distribution in the tissues of mice bearing melanosarcoma after administration of DL-tyrosine labeled with radioactive carbon.
Topics: Amino Acids; Animals; Carbon; Dietary Proteins; Melanoma; Mice; Radioactivity; Tyrosine | 1948 |
Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cyclophosphamide; DNA Replication; DNA, Neoplasm; Humans; Interleukins; Lymphocyte Activation; Lymphocytes; Melanins; Melanocytes; Melanoma; Monophenol Monooxygenase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; RNA, Ribosomal, 18S; Skin Neoplasms; Tumor Necrosis Factor-alpha; Tyrosine | 2009 |
A potent activator of melanogenesis identified from small-molecule screening.
Topics: Amides; Animals; Cell Line; Drug Evaluation, Preclinical; Humans; Melanins; Melanocytes; Melanoma; Mice; Monophenol Monooxygenase; Oxidation-Reduction; Phenethylamines; Quinolines; Small Molecule Libraries; Structure-Activity Relationship; Sunscreening Agents; Tyrosine; Ultraviolet Rays | 2009 |
Inhibition of c-Met with the specific small molecule tyrosine kinase inhibitor SU11274 decreases growth and metastasis formation of experimental human melanoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Focal Adhesions; Humans; Indoles; Liver Neoplasms; Melanoma; Mice; Mice, SCID; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-met; RNA Interference; Sulfonamides; Time Factors; Transfection; Tyrosine; Xenograft Model Antitumor Assays | 2010 |
Common pathogenic pathways in melanoma and Parkinson disease.
Topics: Brain Neoplasms; Group VI Phospholipases A2; Humans; Levodopa; Melanoma; Neural Pathways; Parkinson Disease; Tyrosine | 2010 |
Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Transformed; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Melanoma; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Oncogene Proteins; Phosphorylation; RNA, Messenger; Signal Transduction; Tumor Burden; Tyrosine; Xenograft Model Antitumor Assays | 2011 |
Antitumoral and mechanistic studies of ianthelline isolated from the Arctic sponge Stryphnus fortis.
Topics: Animals; Antineoplastic Agents; Biological Products; Breast Neoplasms; Carcinoma; Cell Division; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Female; Humans; Imidazoles; Leukemia; Melanoma; Porifera; Protein Kinase Inhibitors; Sea Urchins; Spindle Apparatus; Tyrosine | 2012 |
An immunoreceptor tyrosine-based inhibition motif in varicella-zoster virus glycoprotein B regulates cell fusion and skin pathogenesis.
Topics: Amino Acid Sequence; Animals; Blotting, Western; Cell Fusion; Cell Line, Tumor; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Giant Cells; HEK293 Cells; Herpesvirus 3, Human; Humans; Immunoreceptor Tyrosine-Based Inhibition Motif; Melanoma; Microscopy, Confocal; Microscopy, Electron, Transmission; Models, Molecular; Mutation; Phosphorylation; Protein Structure, Tertiary; Skin; Transplantation, Heterologous; Tyrosine; Viral Envelope Proteins | 2013 |
Quantitative relationships between pigment-related mRNA and biochemical melanoma markers in melanoma cell lines.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Gene Expression Profiling; Humans; Intramolecular Oxidoreductases; MART-1 Antigen; Melanins; Melanoma; Membrane Glycoproteins; Monophenol Monooxygenase; Neoplasm Proteins; Neoplastic Cells, Circulating; Nerve Growth Factors; Oxidoreductases; Pigmentation; Polymerase Chain Reaction; Proteins; Pyrroles; RNA, Messenger; RNA, Neoplasm; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Tumor Cells, Cultured; Tyrosine | 2002 |
Melanoma progression and serum L-dopa/L-tyrosine ratio: a comparison with S100B.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Bulgaria; Chromatography, High Pressure Liquid; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Nerve Growth Factors; Predictive Value of Tests; Prognosis; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tyrosine | 2002 |
Histamine inhibits the production of interferon-induced protein of 10 kDa in human squamous cell carcinoma and melanoma.
Topics: Carcinoma, Squamous Cell; Chemokine CXCL10; Chemokines, CXC; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation, Neoplastic; Histamine; Humans; Interferon-gamma; Interferon-Stimulated Gene Factor 3; Janus Kinase 1; Janus Kinase 2; Melanoma; Phosphorylation; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H1; Receptors, Histamine H2; Receptors, Histamine H3; Receptors, Histamine H4; Response Elements; RNA, Messenger; Signal Transduction; Skin Neoplasms; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured; Tyrosine | 2002 |
Prognostic significance of reverse transcriptase-polymerase chain reaction-negative sentinel nodes in malignant melanoma.
Topics: Antigens, Neoplasm; Disease-Free Survival; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; MART-1 Antigen; Melanoma; Neoplasm Proteins; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Survival Analysis; Tyrosine | 2003 |
ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Cell Nucleus; Chromones; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; Luciferases; Melanoma; Membrane Glycoproteins; Milk Proteins; Mitogen-Activated Protein Kinases; Models, Biological; Morpholines; Mutation; Phosphatidylinositol 3-Kinases; Phosphorylation; Promoter Regions, Genetic; Signal Transduction; STAT3 Transcription Factor; STAT5 Transcription Factor; TNF-Related Apoptosis-Inducing Ligand; Trans-Activators; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tyrosine | 2003 |
HPLC analysis of pheomelanin degradation products in human urine.
Topics: Acids; Chromatography, High Pressure Liquid; Cysteinyldopa; Hair; Humans; Hydrolysis; Iodine Compounds; Isomerism; Melanins; Melanoma; Tyrosine | 2003 |
Cooperative roles of Fyn and cortactin in cell migration of metastatic murine melanoma.
Topics: Animals; Cell Line, Tumor; Cell Membrane; Cell Movement; Cortactin; Detergents; DNA-Binding Proteins; Fibroblasts; Fibronectins; Immunoblotting; Integrins; Melanoma; Mice; Microfilament Proteins; Octoxynol; Phosphorylation; Plant Proteins; Polylysine; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Signal Transduction; Time Factors; Tyrosine; Up-Regulation | 2003 |
Incorporation of tyrosine-2-C14 by malignant melanoma.
Topics: Humans; Melanoma; Tyrosine | 1955 |
Melanogenuria-evaluation of several commonly used laboratory procedures.
Topics: Humans; Laboratories; Melanoma; Tyrosine | 1961 |
Quantitative determination of C14-tyrosine absorption in melanated and non-melanated mouse tissues.
Topics: Biochemical Phenomena; Humans; Melanoma; Tyrosine | 1959 |
Effects of L-phenylalanine and sodium phenylpyruvate on the formation of melanin from L-tyrosine in melanoma.
Topics: Melanins; Melanoma; Phenylalanine; Phenylpyruvic Acids; Sodium; Tyrosine | 1962 |
Homovanillic acid and its relation to tyrosine metabolism in melanoma.
Topics: Body Fluids; Homovanillic Acid; Humans; Melanoma; Phenylacetates; Tyrosine | 1962 |
Tyrosine metabolism in melanoma.
Topics: Humans; Melanoma; Tyrosine | 1962 |
[Autoradiographic studies on protein and melanin metabolism in different cell types in melanoma in mice (Harding-Passey type)].
Topics: Animals; Autoradiography; Dihydroxyphenylalanine; Melanins; Melanoma; Mice; Neoplasms; Neoplasms, Experimental; Proline; Proteins; Tyrosine | 1962 |
[DIFFERENTIAL DIAGNOSIS OF MALIGNANT MELANOMA].
Topics: Biopsy; Diagnosis, Differential; Granuloma; Hemangioma; Histiocytoma, Benign Fibrous; Histocytochemistry; Humans; Leiomyoma; Melanoma; Neoplasms; Tyrosine; Tyrosine Decarboxylase; Urine | 1964 |
WATER-SOLUBLE MELANIN PREPARATION.
Topics: Animals; Biochemical Phenomena; Biochemistry; Cattle; Chromatography; Dialysis; Eye; Hydrogen-Ion Concentration; Melanins; Melanoma; Renal Dialysis; Specimen Handling; Temperature; Tyrosine; Urine; Water | 1964 |
AN ENZYMATIC AND ELECTRON MICROSCOPIC CHARACTERIZATION OF A VARIANT OF THE CLOUDMAN S-91 MELANOMA.
Topics: Animals; Dihydroxyphenylalanine; Electrons; Enzyme Inhibitors; Histocytochemistry; Melanins; Melanoma; Mice; Microscopy; Microscopy, Electron; Neoplasms, Experimental; Research; Tyrosine; Tyrosine Decarboxylase | 1964 |
MELANOGENESIS: AN AUTORADIOGRAPHIC STUDY AT THE ULTRASTRUCTURAL LEVEL.
Topics: Animals; Autoradiography; Dihydroxyphenylalanine; Electrons; Histocytochemistry; Melanins; Melanoma; Metabolism; Mice; Microscopy; Microscopy, Electron; Neoplasms, Experimental; Research; Skin Neoplasms; Tritium; Tyrosine | 1964 |
OCCURRENCE, ISOLATION AND METABOLIC RELATIONS OF URINARY MELANOGENS IN PATIENTS AFFECTED BY MELANOMA.
Topics: Chromatography; Humans; Indoles; Melanins; Melanoma; Metabolism; Phenols; Tyrosine; Urine | 1964 |
[TYROSINE DEMONSTRATION IN METASTASES OF MALIGNANT MELANOMA. A METHOD OF DIFFERENTIATION OF SATELLITES OF SO-CALLED INDUCED OR MULTIPLE PRIMARY MELANOMA OF THE SKIN].
Topics: Cell Differentiation; Humans; Melanoma; Neoplasm Metastasis; Neoplasms, Second Primary; Skin Neoplasms; Tyrosine; Tyrosine Decarboxylase | 1964 |
[Certain data and considerations on possible means of chemotherapy of melanomas].
Topics: Carbon; Carbon Radioisotopes; Humans; Melanoma; Tyrosine | 1960 |
Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker.
Topics: Adult; Biomarkers, Tumor; Cell Line, Tumor; Chromatography, High Pressure Liquid; Female; Humans; Levodopa; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nerve Growth Factors; Prognosis; Recurrence; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Time Factors; Tyrosine | 2003 |
Synthesis and selective in vitro anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
Topics: 3T3 Cells; Acetylcysteine; Animals; Antineoplastic Agents; Cell Line, Tumor; Cysteamine; Glutathione; Inhibitory Concentration 50; Kinetics; Magnetic Resonance Spectroscopy; Melanoma; Melanoma, Experimental; Mice; Models, Chemical; Monophenol Monooxygenase; Phenols; Stereoisomerism; Time Factors; Tyrosine | 2003 |
Effects of combined oral administration and intravenous injection on maintaining decreased systemic tyrosine levels in rats.
Topics: Administration, Oral; Animals; Capsules; Hemoglobins; Injections, Intravenous; Male; Melanoma; Monophenol Monooxygenase; Oxygen; Rats; Rats, Sprague-Dawley; Tyrosine | 2004 |
In vitro and in vivo enzyme studies of polyhemoglobin-tyrosinase.
Topics: Aldehydes; Animals; Blood Circulation Time; Cross-Linking Reagents; Enzyme Stability; Hemoglobins; Injections, Intravenous; Melanoma; Monophenol Monooxygenase; Rats; Rats, Sprague-Dawley; Tyrosine | 2004 |
Targeting of HLA-DR molecules transduces agonistic functional signals in cutaneous melanoma.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Blotting, Western; Cell Aggregation; Cell Division; Electrophoresis, Polyacrylamide Gel; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; HLA-DR Antigens; Humans; Lymphocyte Activation; Melanoma; Molecular Weight; Neoplasm Metastasis; Phosphorylation; Precipitin Tests; Protein-Tyrosine Kinases; Signal Transduction; Skin Neoplasms; Tumor Cells, Cultured; Tyrosine; Up-Regulation | 2004 |
c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Blotting, Western; Cell Division; Female; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Male; Melanoma; Middle Aged; Paraffin Embedding; Phosphorylation; Piperazines; Polymerase Chain Reaction; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyrimidines; RNA, Messenger; Skin Neoplasms; Tumor Cells, Cultured; Tyrosine; Uveal Neoplasms | 2004 |
Ectopic expression of tyrosinase increases melanin synthesis and cell death following UVB irradiation in fibroblasts from familial atypical multiple mole and melanoma (FAMMM) patients.
Topics: Adenoviridae; Blotting, Western; Cell Death; Cell Survival; Dysplastic Nevus Syndrome; Family Health; Fibroblasts; Genetic Techniques; Humans; Melanins; Melanoma; Monophenol Monooxygenase; Nevus, Pigmented; Time Factors; Tyrosine; Ultraviolet Rays; Xeroderma Pigmentosum | 2004 |
CEACAM1 enhances invasion and migration of melanocytic and melanoma cells.
Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Blotting, Western; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Cytoplasm; DNA, Complementary; Dose-Response Relationship, Drug; Humans; Integrin alphaVbeta3; Integrin beta3; Melanocytes; Melanoma; Neoplasm Invasiveness; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Oligopeptides; Protein Structure, Tertiary; Time Factors; Transfection; Tyrosine; Up-Regulation | 2004 |
Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that misfolded full-length proteins are efficient substrates for class I processing and presentation.
Topics: Alanine; Amino Acid Substitution; Animals; Antigen Presentation; Arginine; Cell Line; Cell Line, Tumor; Endoplasmic Reticulum; Epitopes; Glutamine; Histocompatibility Antigens Class I; Intracellular Fluid; Melanoma; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Peptide Fragments; Proteasome Endopeptidase Complex; Protein Folding; Protein Processing, Post-Translational; Protein Transport; Substrate Specificity; Threonine; Transfection; Tyrosine | 2005 |
Are STATS arginine-methylated?
Topics: Animals; Arginine; Blotting, Western; Cell Line, Tumor; DNA-Binding Proteins; Extracellular Signal-Regulated MAP Kinases; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Genes, Reporter; Glutathione Transferase; Humans; Immunoprecipitation; Interferon-alpha; Interferons; Interleukin-6; Lysine; Melanoma; Methylation; Methyltransferases; Mice; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Oncostatin M; p38 Mitogen-Activated Protein Kinases; Peptides; Phosphatidylinositol 3-Kinases; Plasmids; Protein Structure, Tertiary; Receptors, Interleukin-6; Recombinant Fusion Proteins; Recombinant Proteins; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Trans-Activators; Transfection; Tyrosine | 2005 |
PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells.
Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Hypoglycemic Agents; Immunologic Factors; Ligands; Male; Melanoma; Methionine; Phenylalanine; PPAR gamma; Prostaglandin D2; Prostatic Neoplasms; Thiazolidinediones; Tyrosine | 2006 |
Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway.
Topics: Active Transport, Cell Nucleus; Antigens, CD; beta Catenin; Cadherins; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Cells, Cultured; Endothelium, Vascular; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Phosphorylation; Protein Transport; Signal Transduction; Tyrosine; Up-Regulation | 2005 |
Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells.
Topics: Cell Division; Cell Line, Tumor; Crk-Associated Substrate Protein; Cytoskeletal Proteins; Gangliosides; Humans; Melanoma; Neoplasm Invasiveness; Paxillin; Phenotype; Phosphoproteins; Phosphorylation; Proteins; Retinoblastoma-Like Protein p130; RNA, Small Interfering; Sialyltransferases; Transfection; Tyrosine | 2005 |
A quantum yield map for synthetic eumelanin.
Topics: Biophysics; Energy Transfer; Humans; Melanins; Melanoma; Models, Chemical; Models, Statistical; Oxygen; Photochemistry; Photons; Protein Engineering; Quantum Theory; Skin Neoplasms; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Tyrosine | 2005 |
Involvement of Src family kinases in N-cadherin phosphorylation and beta-catenin dissociation during transendothelial migration of melanoma cells.
Topics: Amino Acid Sequence; beta Catenin; Cadherins; Cell Line, Tumor; Cell Movement; Cells, Cultured; Endothelial Cells; Enzyme Activation; Humans; Melanoma; Molecular Sequence Data; Peptide Mapping; Phosphorylation; Protein Binding; Signal Transduction; src-Family Kinases; Tyrosine | 2006 |
VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.
Topics: Antigens, CD; Cadherins; Cell Adhesion; Cell Membrane; Cytoplasm; Ephrin-A1; Humans; Intercellular Junctions; Melanoma; Neovascularization, Pathologic; Oligonucleotides, Antisense; Phosphorylation; Receptor, EphA2; Signal Transduction; Skin Neoplasms; Tumor Cells, Cultured; Tyrosine | 2006 |
Clinical value of combined determination of plasma L-DOPA/tyrosine ratio, S100B, MIA and LDH in melanoma.
Topics: Aged; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Prospective Studies; S100 Proteins; Sensitivity and Specificity; Skin Neoplasms; Survival Analysis; Tyrosine | 2007 |
New high-performance liquid chromatographic method for sensitive determination of pheomelanin in biological materials by precolumn fluorescence derivatization with naphthalene-2,3-dicarboxaldehyde.
Topics: Animals; Cell Line, Tumor; Chromatography, High Pressure Liquid; Fluorescent Dyes; Hair; Humans; Melanins; Melanoma; Mice; Models, Chemical; Molecular Structure; Naphthalenes; NIH 3T3 Cells; Rats; Reproducibility of Results; Spectrometry, Fluorescence; Tyrosine | 2007 |
Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.
Topics: Antigens, CD; Biomarkers; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Survival; Down-Regulation; Furans; Humans; Immunologic Factors; Immunotherapy; In Vitro Techniques; Interferon-alpha; Killer Cells, Natural; Melanoma; Oligonucleotide Array Sequence Analysis; Phosphorylation; Signal Transduction; Skin Neoplasms; STAT1 Transcription Factor; Thiophenes; Tyrosine | 2007 |
Distinction of malignant melanoma and epidermis using IR micro-spectroscopy and statistical methods.
Topics: Biomarkers, Tumor; Cytosine; Discriminant Analysis; DNA, Neoplasm; Epidermis; Guanine; Humans; Melanoma; Microspectrophotometry; Skin Neoplasms; Spectroscopy, Fourier Transform Infrared; Tyrosine | 2008 |
Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Humans; Melanoma; Neoplasm Proteins; Nitric Oxide; Nitric Oxide Synthase Type II; STAT3 Transcription Factor; Tumor Cells, Cultured; Tyrosine | 2008 |
Urinary phenols in melanoma.
Topics: Chromatography; Dihydroxyphenylalanine; Humans; Melanoma; Normetanephrine; Oxidation-Reduction; Phenols; Tyramine; Tyrosine | 1967 |
Tyrosinase activity in the amelanotic melanoma in golden hamsters.
Topics: Animals; Cricetinae; Dihydroxyphenylalanine; Hydroxylamines; Kidney; Liver; Manometry; Melanoma; Neoplasm Transplantation; Neoplasms, Experimental; Oxygen Consumption; Thiocarbamates; Tyrosine; Tyrosine Decarboxylase | 1967 |
Substrate limiting melanogenic inhibitor in malignant melanomas.
Topics: Animals; Carbon Isotopes; Chromatography; Melanins; Melanoma; Mice; Oxidoreductases; Tyrosine | 1967 |
Correlation between tyrosine hydroxylase activity, melanogenesis, and estradiol binding in human melanoma cells.
Topics: Breast Neoplasms; Cell Line; Cytosol; Estradiol; Fibroblasts; Humans; Kinetics; Levodopa; Melanins; Melanoma; Tamoxifen; Tyrosine; Tyrosine 3-Monooxygenase | 1982 |
Feline sarcoma virus-specific transformation-related proteins and protein kinase activity in tumor cells.
Topics: Animals; Cats; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Fibrosarcoma; Gene Products, gag; Melanoma; Mink; Peptides; Phosphotyrosine; Protein Kinases; Retroviridae; Retroviridae Proteins, Oncogenic; Sarcoma Viruses, Feline; Tumor Virus Infections; Tyrosine; Viral Proteins | 1983 |
Evaluation of transsphenoidal hypophysectomy in the management of patients with advanced malignant melanoma.
Topics: Adult; Evaluation Studies as Topic; Female; Humans; Hypophysectomy; Male; Melanoma; Methyltyrosines; Middle Aged; Neoplasm Metastasis; Palliative Care; Postoperative Complications; Prognosis; Radioimmunoassay; Skin Neoplasms; Tyrosine | 1983 |
Detection and localization of a phosphotyrosine-containing onc gene product in feline tumor cells.
Topics: Animals; Cats; Cell Transformation, Neoplastic; Melanoma; Mink; Neoplasm Proteins; Neoplasms, Experimental; Oncogenes; Phosphotyrosine; Protein Kinases; Protein-Tyrosine Kinases; Retroviridae; Sarcoma, Experimental; Tyrosine | 1983 |
Tyrosinase activity in the medium of human melanoma cell cultures.
Topics: Ascorbic Acid; Catechol Oxidase; Cells, Cultured; Chromatography, High Pressure Liquid; Culture Media; Dihydroxyphenylalanine; Humans; Hydroxylation; Melanoma; Monophenol Monooxygenase; Oxidation-Reduction; Stereoisomerism; Tyrosine | 1983 |
Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
Topics: Animals; Cysteine; Cysteinyldopa; Dihydroxyphenylalanine; Free Radicals; Indoles; Melanins; Melanoma; Mice; Mice, Inbred Strains; Monophenol Monooxygenase; Protein Binding; Rats; Rats, Inbred Strains; Tyrosine | 1983 |
Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
Topics: Catechol Oxidase; Cell Line; Cells, Cultured; Dihydroxyphenylalanine; Humans; Hydroxylation; Melanoma; Monophenol Monooxygenase; Oxidation-Reduction; Substrate Specificity; Tyrosine | 1983 |
Inactivation of human tyrosinase by cysteine. Protection by dopa and tyrosine.
Topics: Catalase; Catechol Oxidase; Cells, Cultured; Cysteine; Humans; In Vitro Techniques; Levodopa; Melanoma; Monophenol Monooxygenase; Superoxide Dismutase; Tyrosine | 1984 |
Oxidation of tyrosine to dopachrome by peroxidase isolated from murine melanoma.
Topics: Animals; Clone Cells; In Vitro Techniques; Indolequinones; Indoles; Isoenzymes; Melanins; Melanoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Peroxidase; Peroxidases; Quinones; Tyrosine | 1982 |
Estrogen receptor in malignant melanoma: fact or artefact?
Topics: Breast Neoplasms; Catechol Oxidase; Durapatite; Estradiol; Humans; Hydroxyapatites; In Vitro Techniques; Ligands; Melanoma; Models, Biological; Monophenol Monooxygenase; Oxidation-Reduction; Receptors, Estrogen; Tyrosine | 1983 |
The role of NADP-dependent dehydrogenases in hydroxylation of tyrosine in hamster melanoma.
Topics: Animals; Cricetinae; Dihydroxyphenylalanine; Electrophoresis, Polyacrylamide Gel; Hydroxylation; Melanoma; Monophenol Monooxygenase; NADP; NADPH Dehydrogenase; Neoplasm Transplantation; Neoplasms, Experimental; Oxidoreductases; Tyrosine | 1983 |
Effect of triamcinolone acetonide on tyrosinase activity in a human melanoma cell line.
Topics: Carbon Radioisotopes; Catechol Oxidase; Cell Cycle; Cell Line; DNA Replication; Humans; Kinetics; Levodopa; Melanoma; Monophenol Monooxygenase; Triamcinolone Acetonide; Tritium; Tyrosine | 1984 |
Effect of theophylline on the transport of tyrosine in cultured B-16 mouse melanoma cells.
Topics: Animals; Biological Transport, Active; Cell Count; Cell Line; Cells, Cultured; Cycloheximide; Melanoma; Mice; Monophenol Monooxygenase; Skin Neoplasms; Sodium; Stimulation, Chemical; Theophylline; Tyrosine | 1984 |
Aminoacids--precursors of melanin synthesis in hamster melanoma.
Topics: Amino Acids; Animals; Cricetinae; Ferrous Compounds; Iron; Levodopa; Male; Melanins; Melanoma; Mesocricetus; Neoplasm Transplantation; Phenylalanine; Tryptophan; Tyrosine | 1984 |
Phenylalanine lowers melanin synthesis in mammalian melanocytes by reducing tyrosine uptake: implications for pigment reduction in phenylketonuria.
Topics: Animals; Cricetinae; Humans; Melanins; Melanocytes; Melanoma; Monophenol Monooxygenase; Neoplasms, Experimental; Phenylalanine; Phenylketonurias; Skin Neoplasms; Skin Pigmentation; Tyrosine | 1980 |
Mammalin tyrosinase. Stoichiometry and measurement of reaction products.
Topics: Amino Acids; Animals; Basidiomycota; Catechol Oxidase; Dihydroxyphenylalanine; Melanins; Melanocytes; Melanoma; Mice; Monophenol Monooxygenase; Tyrosine | 1980 |
Sex steroid receptor analysis in human melanoma.
Topics: Adult; Aged; Estradiol; Estrogen Antagonists; Female; Humans; Levodopa; Male; Melanins; Melanoma; Middle Aged; Monophenol Monooxygenase; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Tyrosine | 1980 |
Genetic basis of pigmentation and its disorders.
Topics: Albinism; Animals; Cell Differentiation; Color; Humans; Lentigo; Melanins; Melanocytes; Melanoma; Mice; Monophenol Monooxygenase; Nevus; Phenylalanine; Pigmentation; Pigmentation Disorders; Skin; Syndrome; Tyrosine | 1981 |
Effect of DOPA-loading on glutathione-dependent 5-S-cysteinyldopa genesis in melanoma cells in vitro.
Topics: Animals; Cells, Cultured; Cricetinae; Culture Media; Cysteine; Cysteinyldopa; Dihydroxyphenylalanine; Drug Synergism; Fibroblasts; Glutathione; Humans; In Vitro Techniques; Melanoma; Mice; Neoplasms, Experimental; Skin Neoplasms; Stimulation, Chemical; Tyrosine | 1982 |
Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin.
Topics: Catechol Oxidase; Cells, Cultured; Dihydroxyphenylalanine; Indoles; Kinetics; Melanins; Melanoma; Monophenol Monooxygenase; Neoplasms, Experimental; Substrate Specificity; Tyrosine | 1982 |
Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Carbidopa; Cell Line; Diet; Drug Synergism; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Levodopa; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Phenylalanine; Tyrosine | 1983 |
Transforming growth factor and epidermal growth factor stimulate the phosphorylation of a synthetic, tyrosine-containing peptide in a similar manner.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Cell Transformation, Neoplastic; Cells, Cultured; Epidermal Growth Factor; Humans; Kinetics; Melanoma; Membrane Proteins; Mice; Peptides; Phosphorylation; Transforming Growth Factors; Tyrosine | 1982 |
Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy.
Topics: Animals; Carbidopa; Diet; Drug Evaluation, Preclinical; Female; Levodopa; Melanoma; Mice; Neoplasms, Experimental; Phenylalanine; Tyrosine | 1982 |
Studies on the transport of tyrosine, leucine, and methionine in cultured B-16 mouse melanoma cells.
Topics: Animals; Cells, Cultured; Kinetics; Leucine; Melanoma; Methionine; Mice; Neoplasms, Experimental; Sodium; Theophylline; Tyrosine | 1982 |
An ultrastructural study of albinistic B-14 melanoma cells.
Topics: Animals; Cell Line; Chromatography, Thin Layer; Culture Media; Levodopa; Melanoma; Mice; Mice, Inbred C57BL; Microscopy, Electron; Neoplasms, Experimental; Pigmentation; Tyrosine | 1981 |
An experimental approach to the chemotherapy of melanoma.
Topics: Antineoplastic Agents; Dopamine; Humans; Indoles; Levodopa; Melanins; Melanoma; Skin Neoplasms; Tyrosine | 1980 |
Resistance of melanoma cell lines to interferons correlates with reduction of IFN-induced tyrosine phosphorylation. Induction of the anti-viral state by IFN is prevented by tyrosine kinase inhibitors.
Topics: 2',5'-Oligoadenylate Synthetase; Antiviral Agents; Benzoquinones; Drug Resistance; Genistein; GTP-Binding Proteins; Humans; Interferons; Isoflavones; Lactams, Macrocyclic; Melanoma; Myxovirus Resistance Proteins; Neoplasm Proteins; Phosphorylation; Protein Biosynthesis; Protein-Tyrosine Kinases; Quinones; Rifabutin; Semliki forest virus; Tumor Cells, Cultured; Tyrosine | 1995 |
Phosphorylation of human plasminogen activators and plasminogen.
Topics: Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Humans; Immunoblotting; Melanoma; Phosphorylation; Phosphoserine; Phosphotyrosine; Plasminogen; Plasminogen Activators; Tissue Plasminogen Activator; Tumor Cells, Cultured; Tyrosine; Urokinase-Type Plasminogen Activator | 1995 |
pp125FAK in human melanocytes and melanoma: expression and phosphorylation.
Topics: Antibodies; Blotting, Western; Cell Adhesion Molecules; Cell Line; Electrophoresis, Polyacrylamide Gel; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression; Humans; Integrin beta1; Integrins; Macromolecular Substances; Melanocytes; Melanoma; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Receptor, Insulin; Tumor Cells, Cultured; Tyrosine | 1995 |
Melanoma growth stimulatory activity signaling through the class II interleukin-8 receptor enhances the tyrosine phosphorylation of Crk-associated substrate, p130, and a 70-kilodalton protein.
Topics: Antigens, CD; Blotting, Western; Cell Line; Cell Membrane; Chemokine CXCL1; Chemokines, CXC; Chemotactic Factors; Crk-Associated Substrate Protein; Cytosol; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Melanoma; Molecular Weight; Neoplasm Proteins; Oncogene Protein v-crk; Phosphoproteins; Phosphorylation; Phosphotransferases; Placenta; Proteins; Receptors, Interleukin; Receptors, Interleukin-8A; Retinoblastoma-Like Protein p130; Retroviridae Proteins, Oncogenic; Serine; Transfection; Tyrosine | 1995 |
Melanins in IGR 1 melanoma cells.
Topics: Chromatography, Liquid; Cysteinyldopa; Dicarboxylic Acids; Humans; Hydrolysis; Mass Spectrometry; Melanins; Melanoma; Monophenol Monooxygenase; Neoplasm Proteins; Oxidation-Reduction; Potassium Permanganate; Pyrroles; Sulfur; Thiazoles; Tumor Cells, Cultured; Tyrosine | 1994 |
Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells.
Topics: Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Melanoma; Mice; Phenylalanine; Radiation-Sensitizing Agents; Time Factors; Tumor Cells, Cultured; Tyrosine | 1994 |
Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma.
Topics: Benzoquinones; Catechols; Cysteinyldopa; Dihydroxyphenylalanine; Dopamine; Humans; Indoles; Melanins; Melanoma; Models, Chemical; Phenol; Phenols; Pigments, Biological; Tyrosine | 1993 |
Influence of melanin on pO2 measurement in vitro and in vivo.
Topics: Animals; Humans; Melanins; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Oxygen; Tumor Cells, Cultured; Tyrosine | 1996 |
Malignant melanoma of the head and neck. Clinical and immunological considerations.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Neoplasm; Biomarkers, Tumor; Disease Progression; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Israel; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Scalp; Sex Factors; Skin Neoplasms; Sunlight; Tyrosine | 1996 |
Enzymatic and non-enzymatic oxygenation of tyrosine.
Topics: Animals; Catalase; Cattle; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Humans; Hydrogen Peroxide; Melanoma; Monophenol Monooxygenase; Oxygen; Substrate Specificity; Superoxide Dismutase; Superoxides; Tumor Cells, Cultured; Tyrosine; Xanthine; Xanthine Oxidase; Xanthines | 1996 |
PCR-mediated differential display and cloning of a melanocyte gene decreased in malignant melanoma and up-regulated with sensitization to DNA damage.
Topics: Base Sequence; Bromodeoxyuridine; Cell Differentiation; Cloning, Molecular; DNA Damage; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Melanocytes; Melanoma; Molecular Sequence Data; Polymerase Chain Reaction; Radiation-Sensitizing Agents; Resting Phase, Cell Cycle; RNA, Messenger; RNA, Neoplasm; Sequence Analysis, DNA; Tumor Cells, Cultured; Tyrosine; Ultraviolet Rays | 1996 |
Molecular approach to the nucleo-melanosomal interaction in human melanoma cells.
Topics: Animals; Cell Nucleus; DNA Topoisomerases, Type I; DNA-Binding Proteins; DNA, Neoplasm; DNA, Superhelical; Electrophoresis; Enzyme Inhibitors; Fibroblasts; Humans; Indoles; Liposomes; Male; Melanoma; Monophenol Monooxygenase; Nucleic Acid Denaturation; Oxidation-Reduction; Plasmids; Prostatic Neoplasms; Rabbits; Tritium; Tumor Cells, Cultured; Tyrosine | 1997 |
Sister chromatid exchange (SCE) rates in human melanoma cells as an index of mutagenesis.
Topics: Culture Media; Humans; Melanins; Melanoma; Sister Chromatid Exchange; Tumor Cells, Cultured; Tyrosine | 1997 |
Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries.
Topics: alpha-Fetoproteins; Amino Acid Sequence; Animals; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Asialoglycoproteins; Binding, Competitive; Breast Neoplasms; Carcinoma; Cell Aggregation; Fetuins; Humans; Lectins; Melanoma; Mice; Molecular Sequence Data; Peanut Agglutinin; Peptide Library; Peptides; Protein Binding; Sequence Homology, Amino Acid; Serum Albumin, Bovine; Tumor Cells, Cultured; Tyrosine | 1997 |
Inactivation of ribonucleotide reductase in tumour cells and inhibition of tumour cell growth by p-alkoxyphenols.
Topics: Animals; Cell Division; Electron Spin Resonance Spectroscopy; Enzyme Activation; HL-60 Cells; Humans; Liver Neoplasms, Experimental; Melanoma; Phenols; Rats; Ribonucleotide Reductases; Tumor Cells, Cultured; Tyrosine | 1997 |
Determination of the L-DOPA/L-tyrosine ratio in human plasma by high-performance liquid chromatography. Usefulness as a marker in metastatic malignant melanoma.
Topics: Biomarkers, Tumor; Calibration; Chromatography, High Pressure Liquid; Circadian Rhythm; Humans; Hydrogen-Ion Concentration; Levodopa; Linear Models; Melanins; Melanoma; Reproducibility of Results; Skin Neoplasms; Spectrometry, Fluorescence; Tyrosine | 1997 |
Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.
Topics: Antineoplastic Agents; Cytokines; DNA-Binding Proteins; Drug Resistance, Neoplasm; Humans; Interferon-alpha; Interferon-Stimulated Gene Factor 3; Interferon-Stimulated Gene Factor 3, gamma Subunit; Interferons; Janus Kinase 1; Melanoma; Phosphorylation; Protein-Tyrosine Kinases; Proteins; Signal Transduction; STAT1 Transcription Factor; STAT2 Transcription Factor; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; TYK2 Kinase; Tyrosine; Ubiquitins | 1997 |
Activation of beta1 integrin signaling stimulates tyrosine phosphorylation of p190RhoGAP and membrane-protrusive activities at invadopodia.
Topics: Amino Acid Sequence; Cell Adhesion; GTPase-Activating Proteins; Guanine Nucleotide Exchange Factors; Humans; Integrin beta1; Melanoma; Nuclear Proteins; Phosphoproteins; Phosphorylation; Repressor Proteins; Signal Transduction; Tumor Cells, Cultured; Tyrosine | 1998 |
Ligand binding to macrophage scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway.
Topics: Cell Line; Enzyme Inhibitors; Humans; Ligands; Lipoproteins, LDL; Melanoma; Phosphorylation; Polysaccharides; Protein Binding; Protein Kinase C; Protein-Tyrosine Kinases; Receptors, Immunologic; Receptors, Scavenger; Scavenger Receptors, Class A; Signal Transduction; Tyrosine; Up-Regulation; Urokinase-Type Plasminogen Activator | 1998 |
The major myristoylated PKC substrate (MARCKS) is involved in cell spreading, tyrosine phosphorylation of paxillin, and focal contact formation.
Topics: Cell Adhesion; Cell Adhesion Molecules; Cell Size; Choroid Neoplasms; Cytoskeletal Proteins; Humans; Intracellular Signaling Peptides and Proteins; Melanoma; Membrane Proteins; Myristoylated Alanine-Rich C Kinase Substrate; Paxillin; Phosphoproteins; Phosphorylation; Proteins; Transfection; Tumor Cells, Cultured; Tyrosine; Vinculin | 1997 |
Melanin-concentrating hormone binding sites in human SVK14 keratinocytes.
Topics: Amino Acid Sequence; Animals; Binding Sites; Carcinoma, Squamous Cell; Cell Line, Transformed; Cell Membrane; Humans; Hypothalamic Hormones; Iodine Radioisotopes; Keratinocytes; Melanins; Melanoma; Molecular Sequence Data; Neuroglia; PC12 Cells; Phenylalanine; Pituitary Hormones; Radioligand Assay; Rats; Receptors, Pituitary Hormone; Tumor Cells, Cultured; Tyrosine | 1997 |
Receptor tyrosine kinase Xmrk mediates proliferation in Xiphophorus melanoma cells.
Topics: 3T3 Cells; Animals; Cell Division; Cyprinodontiformes; Enzyme Activation; Fish Proteins; Melanoma; Mice; Nitriles; Protein Serine-Threonine Kinases; Receptor Protein-Tyrosine Kinases; Tyrosine; Tyrphostins | 1998 |
[Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
Topics: Animals; Antineoplastic Agents; Cysteamine; Cysteine; DNA Damage; Humans; Melanins; Melanoma; Mice; Monophenol Monooxygenase; Oxidative Stress; Phenols; Skin Neoplasms; Substrate Specificity; Tumor Cells, Cultured; Tyrosine | 1998 |
Signalling by the oncogenic receptor tyrosine kinase Xmrk leads to activation of STAT5 in Xiphophorus melanoma.
Topics: Animals; Cyprinodontiformes; DNA-Binding Proteins; DNA, Neoplasm; Enzyme Activation; Fish Proteins; Gene Expression Regulation, Neoplastic; Melanoma; Mice; Milk Proteins; Phosphorylation; Proto-Oncogene Proteins; Rabbits; Receptor Protein-Tyrosine Kinases; Signal Transduction; STAT5 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Tyrosine | 1998 |
Influence of tyrosine and phenylalanine limitation of cytotoxicity of chimeric TGF-alpha toxins on B16BL6 murine melanoma in vitro.
Topics: Animals; Antineoplastic Agents; Carrier Proteins; Cell Membrane; Culture Media; Epidermal Growth Factor; Heparin; Melanoma; Mice; Phenylalanine; Proteoglycans; Recombinant Fusion Proteins; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tyrosine | 1998 |
Several noncontiguous domains of CDK4 are involved in binding to the P16 tumor suppressor protein.
Topics: Arginine; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinases; Cysteine; Glutathione Transferase; Humans; Melanoma; Mutagenesis, Site-Directed; Mutation; Proto-Oncogene Proteins; Recombinant Fusion Proteins; Structure-Activity Relationship; Tyrosine | 1998 |
Tissue-specific expression of beta-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness.
Topics: 3T3 Cells; Adenomatous Polyposis Coli; Adult; Animals; beta Catenin; Cadherins; Calcium-Calmodulin-Dependent Protein Kinases; Cell Differentiation; Cell Line; Cell Membrane; Cytoplasm; Cytoskeletal Proteins; Dogs; Epithelium; Glycogen Synthase Kinase 3; Humans; Melanoma; Mesoderm; Mice; Neoplasm Invasiveness; Phenotype; Phosphorylation; Protein Tyrosine Phosphatases; Staining and Labeling; Trans-Activators; Tumor Cells, Cultured; Tyrosine; Uveal Neoplasms; Vanadates | 1998 |
Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency.
Topics: Animals; Apoptosis; Calcium; Cell Adhesion Molecules; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; G1 Phase; Humans; Intracellular Fluid; Melanoma; Melanoma, Experimental; Mice; Phenylalanine; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-myc; Resting Phase, Cell Cycle; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tyrosine | 1999 |
L-[1-11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Hypothermia, Induced; Leg; Male; Melanoma; Melphalan; Middle Aged; Radiopharmaceuticals; Recombinant Proteins; Sarcoma; Sensitivity and Specificity; Skin Neoplasms; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha; Tyrosine | 1999 |
Development of metastases in malignant melanoma is associated with an increase in the plasma L-dopa/L-tyrosine ratio.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; Humans; Levodopa; Longitudinal Studies; Male; Melanoma; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Reference Values; Skin Neoplasms; Tyrosine | 1999 |
Inhibition of L-tyrosine-induced micronuclei production by phenylthiourea in human melanoma cells.
Topics: Apoptosis; Cell Nucleus; Cytochalasin B; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Melanoma; Melanoma, Amelanotic; Micronucleus Tests; Monophenol Monooxygenase; Phenylthiourea; Skin Neoplasms; Tumor Cells, Cultured; Tyrosine | 1999 |
Cytoplasmic STAT proteins associate prior to activation.
Topics: Amino Acid Sequence; Animals; Carcinoma, Hepatocellular; COS Cells; Cross Reactions; Cytoplasm; Dimerization; DNA-Binding Proteins; Humans; Interleukin-6; Liver Neoplasms; Melanoma; Molecular Sequence Data; Phosphorylation; Precipitin Tests; STAT1 Transcription Factor; STAT3 Transcription Factor; Trans-Activators; Transfection; Tumor Cells, Cultured; Tyrosine | 2000 |
Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
Topics: Buthionine Sulfoximine; Cells, Cultured; Cysteine; Cysteinyldopa; Dihydroxyphenylalanine; Glutathione; Humans; Infant, Newborn; Male; Melanins; Melanocytes; Melanoma; Melanosomes; Monophenol Monooxygenase; Neoplasm Proteins; Skin Neoplasms; Tumor Cells, Cultured; Tyrosine | 1999 |
Expression of the inducible isoform of nitric oxide synthase in pigment cell lesions of the skin.
Topics: Biomarkers, Tumor; Disease Progression; Enzyme Induction; Humans; Isoenzymes; Macrophages; Melanoma; Neoplasm Metastasis; Nevus; Nitric Oxide Synthase; Skin Neoplasms; Tyrosine | 2000 |
Integrin alpha2beta1 recognizes laminin-2 and induces C-erb B2 tyrosine phosphorylation in metastatic human melanoma cells.
Topics: Collagenases; Humans; Integrins; Laminin; Melanoma; Phenotype; Phosphorylation; Receptor, ErbB-2; Receptors, Collagen; Tumor Cells, Cultured; Tyrosine | 1999 |
[Tyrosine metabolism, antioxidative system and free radical lipid oxidative processes in children with pigmented nevus and melanoma].
Topics: Antioxidants; Biomarkers, Tumor; Child; Child, Preschool; Female; Free Radical Scavengers; Humans; Infant; Lipid Peroxidation; Male; Malondialdehyde; Melanoma; Nevus, Pigmented; Skin Neoplasms; Tyrosine | 2000 |
Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events.
Topics: Actins; Animals; Cell Movement; Enzyme Inhibitors; Glucose-6-Phosphate Isomerase; Isoenzymes; Lipoxygenase; Lipoxygenase Inhibitors; Melanoma; Mice; Microscopy, Confocal; Phosphorylation; Protein Kinase C; Protein Kinase C-alpha; Proteins; Serine; Signal Transduction; Tumor Cells, Cultured; Tyrosine | 1999 |
Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plasminogen activator inhibitors.
Topics: Animals; Cell Adhesion; Culture Media, Conditioned; Melanoma; Mice; Neoplasm Invasiveness; Phenylalanine; Plasminogen Activators; Plasminogen Inactivators; Tissue Plasminogen Activator; Tumor Cells, Cultured; Tyrosine; Urokinase-Type Plasminogen Activator | 1999 |
Altered regulation of cell cycle machinery involved in interleukin-1-induced G(1) and G(2) phase growth arrest of A375S2 human melanoma cells.
Topics: Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; G1 Phase; G2 Phase; Humans; Interleukin-1; Melanoma; Phosphorylation; Retinoblastoma Protein; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tyrosine | 2001 |
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival.
Topics: Adolescent; Adult; Female; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prognosis; Time Factors; Treatment Outcome; Tyrosine | 2000 |
Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Topics: Antibiotics, Antineoplastic; Benzoquinones; beta Catenin; Cadherins; Cell Movement; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Cytoskeletal Proteins; Humans; Lactams, Macrocyclic; Melanoma; Multienzyme Complexes; Nerve Tissue Proteins; Phosphorylation; Point Mutation; Proteasome Endopeptidase Complex; Protein Tyrosine Phosphatases; Quinones; Receptor-Like Protein Tyrosine Phosphatases, Class 2; Receptor-Like Protein Tyrosine Phosphatases, Class 4; Receptor, ErbB-2; Receptors, Cell Surface; Trans-Activators; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Tyrosine | 2001 |
Decreased tissue plasminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine.
Topics: Cell Adhesion; Culture Media, Conditioned; Fibroblasts; Humans; Infant; Melanoma; Neoplasm Invasiveness; Phenylalanine; Plasminogen Activators; Plasminogen Inactivators; Skin; Sp1 Transcription Factor; Tissue Plasminogen Activator; Transcription Factor AP-1; Tumor Cells, Cultured; Tyrosine; Urokinase-Type Plasminogen Activator | 2001 |
Evaluation of standard tyrosinase RT-PCR in melanoma patients by the use of the LightCycler system.
Topics: Adult; Aged; Female; Humans; Male; Melanoma; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; Tyrosine | 2001 |
Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
Topics: Humans; Melanoma; Neovascularization, Pathologic; Oligonucleotides, Antisense; Phosphorylation; Receptor Protein-Tyrosine Kinases; Receptor, EphA2; Tumor Cells, Cultured; Tyrosine; Uveal Neoplasms | 2001 |
Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity.
Topics: CDC2-CDC28 Kinases; cdc25 Phosphatases; Cell Cycle Proteins; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; DNA-Binding Proteins; G1 Phase; Humans; Interleukin-6; Janus Kinase 1; MAP Kinase Kinase 1; Melanoma; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Retinoblastoma Protein; Signal Transduction; Skin Neoplasms; STAT3 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tyrosine | 2001 |
cis Interaction of the cell adhesion molecule CEACAM1 with integrin beta(3).
Topics: Antigens, CD; Antigens, Differentiation; Binding Sites; Cell Adhesion Molecules; Chromatography, Affinity; Colonic Neoplasms; Endometrium; Female; Granulocytes; Humans; Integrin beta3; Melanoma; Microscopy, Confocal; Phosphorylation; Platelet Membrane Glycoproteins; Pregnancy; Pregnancy Trimester, First; Tumor Cells, Cultured; Tyrosine | 2001 |
Integrin alphavbeta3 mediates K1735 murine melanoma cell motility in vivo and in vitro.
Topics: Animals; Antigens, CD; Cell Movement; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; In Vitro Techniques; Integrin beta3; Melanoma; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Phosphorylation; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Receptors, Vitronectin; Signal Transduction; src-Family Kinases; Tumor Cells, Cultured; Tyrosine | 2001 |
Specific amino acid deficiency alters the expression of genes in human melanoma and other tumor cell lines.
Topics: Blotting, Western; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Melanoma; Mitogen-Activated Protein Kinase Kinases; Phenylalanine; Phosphorylation; Prostatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Tyrosine | 2001 |
Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling.
Topics: Actin Cytoskeleton; Cell Adhesion; Cell Membrane; Cell Size; Ephrin-A5; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Membrane Proteins; Mutation; Phosphotransferases; Protein Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-crk; Pseudopodia; Receptor Protein-Tyrosine Kinases; Receptor, EphA7; rho GTP-Binding Proteins; Tumor Cells, Cultured; Tyrosine | 2002 |
Acceptability and tolerance of a low tyrosine and phenylalanine diet in patients with advanced cancer -- a pilot study.
Topics: Adult; Aged; Breast Neoplasms; Depression; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nutritional Status; Phenylalanine; Pilot Projects; Quality of Life; Treatment Outcome; Tryptophan; Tyrosine | 2002 |
Activation of caspases and cleavage of Bid are required for tyrosine and phenylalanine deficiency-induced apoptosis of human A375 melanoma cells.
Topics: Amino Acid Chloromethyl Ketones; Amino Acids, Aromatic; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Carrier Proteins; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; Cytochrome c Group; Fas Ligand Protein; fas Receptor; Humans; Ligands; Melanoma; Membrane Glycoproteins; Mitochondria; Models, Biological; Phenylalanine; Time Factors; Tumor Cells, Cultured; Tyrosine; Ubiquinone | 2002 |
PHrmonal specificity of the melanotropin-sensitive adenylate cyclase of mouse melanoma and effect of cyclic AMP on the tyrosinase activity of mouse melanoma cells, in vitro.
Topics: Adenosine Triphosphate; Adenylyl Cyclases; Adrenocorticotropic Hormone; Animals; Calcium; Catechol Oxidase; Cyclic AMP; Egtazic Acid; Fluorides; Hydrogen-Ion Concentration; Magnesium; Melanocyte-Stimulating Hormones; Melanoma; Mice; Mice, Inbred Strains; Prostaglandins E; Tyrosine | 1976 |
Characteristics of tyrosinase in B16 melanoma.
Topics: Animals; Electrophoresis, Polyacrylamide Gel; Male; Melanoma; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Neoplasms, Experimental; Peroxidases; Photometry; Skin Neoplasms; Tyrosine; Tyrosine 3-Monooxygenase | 1977 |
Demonstration of 3-methoxytyrosine in the urine of melanoma patients.
Topics: Chromatography, Gas; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Mass Spectrometry; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Tyrosine | 1976 |
Transfer RNATyr of melanoma tissues and cells: relevance to melanin synthesis?
Topics: Amino Acyl-tRNA Synthetases; Animals; Cells, Cultured; Melanins; Melanoma; Monophenol Monooxygenase; RNA, Transfer; RNA, Transfer, Amino Acyl; Skin; Swine; Tyrosine | 1979 |
Tyrosine hydroxylation.
Topics: Animals; Catechol Oxidase; Hydroxylation; Isoenzymes; Melanoma; Mice; Monophenol Monooxygenase; Neoplasms, Experimental; Tyrosine | 1979 |
Examination of hormonally regulated functions in differentially metastasizing melanoma cells.
Topics: Animals; Cell Count; Cell Line; Cyclic AMP; Melanins; Melanocyte-Stimulating Hormones; Melanoma; Mice; Mitosis; Monophenol Monooxygenase; Neoplasm Metastasis; Tyrosine | 1977 |
Effect of dietetric factors on the growth of malignant melanomas.
Topics: Animals; Choroid Neoplasms; Cricetinae; Female; Humans; Melanoma; Phenylalanine; Tyrosine | 1977 |
A patient with malignant melanoma treated with a phenylalanine/tyrosine free diet.
Topics: Choroid Neoplasms; Humans; Male; Melanoma; Middle Aged; Phenylalanine; Tyrosine | 1977 |
Effect of alpha-MSH on the tyrosinase activity and the rate of melanin accumulation of melanoma cells in vitro.
Topics: Animals; Catechol Oxidase; Cells, Cultured; In Vitro Techniques; Levodopa; Melanins; Melanocyte-Stimulating Hormones; Melanoma; Mice; Monophenol Monooxygenase; Neoplasms, Experimental; Puromycin; Tyrosine | 1977 |
Mammalian tyrosinase. Structural and functional interraltionship of isozymes.
Topics: Animals; Catechol Oxidase; Isoenzymes; Kinetics; Melanocytes; Melanoma; Mice; Monophenol Monooxygenase; Neuraminidase; Peptide Hydrolases; Phospholipases; Trypsin; Tyrosine | 1978 |
Mammalian tyrosinase: isolation by a simple new procedure and characterization of its steric requirements for cofactor activity.
Topics: Animals; Catechol Oxidase; Dihydroxyphenylalanine; Kinetics; Melanins; Melanocytes; Melanoma; Mice; Monophenol Monooxygenase; Stereoisomerism; Structure-Activity Relationship; Tyrosine | 1978 |
Mammalian melanocytes do not use phenylalanine for melanin synthesis.
Topics: Animals; Cell Line; Cricetinae; Cycloheximide; Leucine; Melanins; Melanocytes; Melanoma; Phenylalanine; Pronase; Thiouracil; Tyrosine | 1977 |
Tyrosine utilization by cultured melanoma cells: analysis of melanin biosynthesis using [14 C]Tyrosine and [14C]Thiouracil.
Topics: Animals; Cell Line; Cricetinae; Cycloheximide; Melanins; Melanoma; Neoplasms, Experimental; Stimulation, Chemical; Thiouracil; Tyrosine | 1979 |
Melanogenesis in human melanomas.
Topics: Catechol Oxidase; Cell Fractionation; Cold Temperature; Dihydroxyphenylalanine; Electrophoresis, Disc; Humans; In Vitro Techniques; Isoenzymes; Melanins; Melanoma; Tyrosine | 1975 |
Inability of murine melanoma melanosomal "tyrosinase" (L-dopa oxidase) to oxidize tyrosine to melanin in polyacrylamide gel systems.
Topics: Animals; Catechol Oxidase; Cell Line; Electrophoresis, Polyacrylamide Gel; Melanins; Melanocytes; Melanoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Organoids; Oxidation-Reduction; Tyrosine | 1975 |
Ultrastructural tyrosine reaction in hamster melanoma.
Topics: Animals; Catechol Oxidase; Cricetinae; Dihydroxyphenylalanine; Endoplasmic Reticulum; Hydroxylation; Melanoma; Neoplasm Transplantation; Neoplasms, Experimental; Oxidation-Reduction; Transplantation, Homologous; Tyrosine | 1975 |
Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro.
Topics: Cells, Cultured; Cycloheximide; Levodopa; Melanins; Melanocyte-Stimulating Hormones; Melanoma; Neoplasms, Experimental; Theophylline; Tyrosine | 1977 |
Malignant melanomata arising in the nasal mucous membrane.
Topics: Adolescent; Female; Humans; Male; Melanocytes; Melanoma; Middle Aged; Nasal Mucosa; Nose Neoplasms; Tyrosine | 1976 |
Antibodies and antigen expression in human melanoma detected by the immune adherence test.
Topics: Antibodies, Neoplasm; Antibody Formation; Antibody Specificity; Antigens, Neoplasm; Autoradiography; Cell Division; Cell Membrane; Cells, Cultured; Complement System Proteins; Cross Reactions; Fluorescent Antibody Technique; Hot Temperature; Humans; Immune Adherence Reaction; Melanoma; Time Factors; Tyrosine | 1975 |
Studies of tumor cell lines derived from patients with malignant melanoma.
Topics: Animals; Animals, Newborn; Cell Line; Culture Media; Culture Techniques; Humans; Melanins; Melanoma; Mice; Neoplasm Transplantation; Tyrosine | 1975 |
Some biological properties and an in vivo evaluation of tyrosine phenol-lyase on growth of B-16 melanoma.
Topics: Animals; Female; Lactate dehydrogenase-elevating virus; Lyases; Male; Melanoma; Mice; Neoplasms, Experimental; Phenylalanine; Tyrosine; Tyrosine Phenol-Lyase | 1976 |
Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
Topics: Animals; Bucladesine; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; DNA; Hepatocyte Growth Factor; Humans; Melanocytes; Melanoma; Mice; Phosphorylation; Protein Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Signal Transduction; Tyrosine | 1992 |
Induction of tyrosinase in human melanoma cells by L-tyrosine phosphate and cytochalasin D.
Topics: Blotting, Northern; Cytochalasin D; DNA; Enzyme Induction; Humans; Melanoma; Monophenol Monooxygenase; Phosphotyrosine; RNA Processing, Post-Transcriptional; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Tyrosine; Tyrosine 3-Monooxygenase | 1992 |
5,6-Dihydroxyindole-2-carboxylic acid is incorporated in mammalian melanin.
Topics: Animals; Cell Line; Indoles; Melanins; Melanocytes; Melanoma; Mice; Tumor Cells, Cultured; Tyrosine | 1992 |
Modulation of growth in normal and malignant melanocytic cells by all-trans retinoic acid.
Topics: Animals; Cell Division; Cells, Cultured; Dendrites; Dose-Response Relationship, Drug; Humans; Male; Melanins; Melanocytes; Melanoma; Mice; Tretinoin; Tumor Cells, Cultured; Tyrosine | 1992 |
Tyrosine transport in a human melanoma cell line as a basis for selective transport of cytotoxic analogues.
Topics: Amino Acids; Amino Acids, Cyclic; Biological Transport, Active; Cysteine; Drug Delivery Systems; Evaluation Studies as Topic; Humans; Kinetics; Melanoma; Sodium; Tumor Cells, Cultured; Tyrosine | 1991 |
Ribonucleotide reductase in melanoma tissue. EPR detection in human amelanotic melanoma and quenching of the tyrosine radical by 4-hydroxyanisole.
Topics: Animals; Anisoles; Carcinoma, Ehrlich Tumor; Cell Division; Electron Spin Resonance Spectroscopy; Free Radicals; Melanoma; Mice; Mice, Inbred ICR; Ribonucleotide Reductases; Tyrosine | 1991 |
L-tyrosine induces tyrosinase expression via a posttranscriptional mechanism.
Topics: Animals; Melanins; Melanoma; Monophenol Monooxygenase; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Tyrosine | 1991 |
L-tyrosine-binding proteins on melanoma cells.
Topics: Animals; Antibodies; Blotting, Western; Carbon Radioisotopes; Chromatography, Affinity; Cricetinae; Levodopa; Melanoma; Molecular Weight; Monophenol Monooxygenase; Phenylalanine; Protein Binding; Tumor Cells, Cultured; Tyrosine | 1991 |
Selective uptake of 2-thiouracil into melanin-producing systems depends on chemical binding to enzymically generated dopaquinone.
Topics: Animals; Benzoquinones; Biomarkers, Tumor; Chromatography, Gel; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Dihydroxyphenylalanine; Kinetics; Magnetic Resonance Spectroscopy; Melanins; Melanoma; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Oxygen Consumption; Thiouracil; Tyrosine | 1990 |
Differentiating effect of L-tyrosine on the human melanoma cell line IIB-MEL-J.
Topics: Cell Adhesion; Cell Separation; Cell Transformation, Neoplastic; Centrifugation, Density Gradient; Humans; Lung Neoplasms; Melanins; Melanoma; Middle Aged; Tumor Cells, Cultured; Tyrosine | 1990 |
Response of natural killer cells from dietary tyrosine- and phenylalanine-restricted mice to biological response modifiers.
Topics: Animals; Antigen-Antibody Complex; Female; Food, Formulated; Immunologic Deficiency Syndromes; Interleukin-2; Killer Cells, Natural; Lymphopenia; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Phenylalanine; Poly I-C; Specific Pathogen-Free Organisms; Tyrosine | 1988 |
Inhibition of melanization in human melanoma cells by a serotonin uptake inhibitor.
Topics: Catecholamines; Cell Line; Dihydroxyphenylalanine; Humans; Melanins; Melanoma; Quinolines; Quipazine; Serotonin; Serotonin Antagonists; Stimulation, Chemical; Tyrosine | 1987 |
Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa.
Topics: Animals; Cricetinae; Levodopa; Melanins; Melanocytes; Melanoma; Monophenol Monooxygenase; Tumor Cells, Cultured; Tyrosine | 1988 |
13C solid-state cross polarization/magic-angle-spinning nuclear magnetic resonance spectra of natural and synthetic melanins.
Topics: Animals; Carbon Isotopes; Choroid; Horse Diseases; Horses; Levodopa; Magnetic Resonance Spectroscopy; Melanins; Melanoma; Oxidation-Reduction; Tyrosine | 1988 |
Interaction between specific dietary factors and experimental chemotherapy of metastatic melanoma.
Topics: Animals; Ascorbic Acid; Diet; Female; Levodopa; Lung Neoplasms; Melanoma; Mice; Mice, Inbred Strains; Phenylalanine; Tyrosine | 1986 |
Modulation of peroxidation in murine melanoma by dietary tyrosine-phenylalanine restriction, levodopa methylester chemotherapy, and sodium ascorbate supplementation.
Topics: Animals; Ascorbic Acid; Diet; Female; Levodopa; Lipid Peroxides; Liver; Malondialdehyde; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Phenylalanine; Tyrosine | 1985 |
The effect of a phenylalanine and tyrosine restricted diet on elemental balance studies and plasma aminograms of patients with disseminated malignant melanoma.
Topics: Adult; Amino Acids; Elements; Female; Food, Formulated; Humans; Male; Melanoma; Middle Aged; Patient Compliance; Phenylalanine; Tyrosine | 1985 |
Fluorometry of a DOPA peptide and its thioether.
Topics: Carbon Isotopes; Catechol Oxidase; Catechols; Chromatography, Paper; Cysteine; Dihydroxyphenylalanine; Dipeptides; Ethers; Fluorescence; Fluorometry; Melanoma; Peptides; Phenylalanine; Pigments, Biological; Spectrophotometry; Sulfhydryl Reagents; Sulfur; Tyrosine | 1971 |
Presence and properties of tyrosinase in sera of melanoma-bearing animals.
Topics: Animals; Blood; Catechol Oxidase; Centrifugation, Density Gradient; Chromatography; Cricetinae; Dihydroxyphenylalanine; Dogs; Humans; Hydrogen-Ion Concentration; Melanoma; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Oxidation-Reduction; Spectrophotometry; Tissue Extracts; Tritium; Tyrosine | 1971 |
Effect of mitomycin C on protein synthesis in human neoplastic cell lines.
Topics: Alanine; Astrocytoma; Dactinomycin; Humans; In Vitro Techniques; Lysine; Melanoma; Mitomycins; Neoplasm Proteins; Protein Hydrolysates; Puromycin; Tyrosine | 1965 |
Levodopa and melanoma.
Topics: Catechol Oxidase; Dihydroxyphenylalanine; Humans; Male; Melanocytes; Melanoma; Parkinson Disease; Skin; Tyrosine | 1973 |
Inability of murine melanoma "tyrosinase" (dopa ozidase) to oxidize tyrosine in the presence or absence of dopa or dihydroxyfumarate cofactor.
Topics: Animals; Catechol Oxidase; Chromatography; Dihydroxyphenylalanine; Fumarates; Hydrogen-Ion Concentration; Melanoma; Methods; Mice; Monophenol Monooxygenase; Neoplasm Transplantation; Neoplasms, Experimental; Oxidation-Reduction; Radioisotopes; Spectrophotometry; Time Factors; Tyrosine | 1973 |
Immunologic homogeneity and electrophoretic heterogeneity of mouse melanoma tyrosinases.
Topics: Animals; Catechol Oxidase; Chromatography, Gel; Cross Reactions; Dihydroxyphenylalanine; Immune Sera; Immunodiffusion; Immunoelectrophoresis; Isoelectric Focusing; Melanoma; Mice; Solubility; Tyrosine | 1973 |
Inhibition of DNA and protein synthesis in melanocytes by a melanoma extract.
Topics: Animals; Carbon Radioisotopes; Catechol Oxidase; Cell Line; Cells, Cultured; Centrifugation, Density Gradient; Chemical Phenomena; Chemistry; Chromatography; Chromatography, Gel; DNA; Electrophoresis, Polyacrylamide Gel; Epinephrine; Hydrocortisone; In Vitro Techniques; Leucine; Melanocytes; Melanoma; Mice; Molecular Weight; Protein Biosynthesis; Thymidine; Time Factors; Tritium; Tyrosine | 1974 |
Quantitative measurement of melanin as tyrosine equivalents and as weight of purified melanin.
Topics: Animals; Basidiomycota; Catechol Oxidase; Clone Cells; Colorimetry; Hair; Hydrochloric Acid; Hydroxides; Melanins; Melanoma; Methods; Mice; Mice, Inbred C57BL; Molecular Weight; Neoplasms, Experimental; Pigmentation; Quaternary Ammonium Compounds; Solvents; Spectrophotometry; Tyrosine | 1973 |
Peroxidase, "protyrosinase," and the multiple forms of tyrosinase in mice.
Topics: Animals; Biphenyl Compounds; Catalase; Catechol Oxidase; Dihydroxyphenylalanine; Electrophoresis, Polyacrylamide Gel; Enzyme Precursors; Hair; Hydroxylation; Melanins; Melanocytes; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Peroxidases; Pigmentation; Trypsin; Tyrosine | 1973 |
Inhibition of growth of transplantable melanotic melanoma in golden hamsters (Mesocricetus auratus, Waterhouse) by chlorpromazine.
Topics: Acid Phosphatase; Animals; Catechol Oxidase; Cathepsins; Chlorpromazine; Cricetinae; Liver; Male; Melanins; Melanoma; Neoplasm Transplantation; Neoplasms, Experimental; Proteins; Tyrosine | 1973 |
Inhibiting effect of chloroquine diphosphate on the growth of tumors and activity of some acid hydrolases of a melanotic melanoma in golden hamsters (Mesocricetus auratus, Waterhouse).
Topics: Acid Phosphatase; Animals; Catechol Oxidase; Catechols; Cathepsins; Chloroquine; Cricetinae; Liver; Male; Melanins; Melanoma; Neoplasm Transplantation; Sulfatases; Tyrosine | 1973 |
Purification and properties of tyrosinases from Vibrio tyrosinaticus.
Topics: Animals; Antigen-Antibody Reactions; Cadmium; Catechol Oxidase; Chromatography, DEAE-Cellulose; Chromatography, Gel; Cobalt; Copper; Cricetinae; Cross Reactions; Electrophoresis, Polyacrylamide Gel; Iron; Isoenzymes; Kinetics; Manganese; Melanoma; Molecular Weight; Monophenol Monooxygenase; Rabbits; Species Specificity; Spectrophotometry; Tritium; Tyrosine; Ultrafiltration; Vibrio | 1974 |
[Isolation of soluble isoltyrosinases extracted from horse melanoma].
Topics: Animals; Catechol Oxidase; Horse Diseases; Horses; Lyases; Melanoma; Skin Neoplasms; Tyrosine | 1973 |
The influence of certain hormones and chemicals on mammalian pigment cells.
Topics: Adrenocorticotropic Hormone; Animals; Ascorbic Acid; Chromatophores; Colchicine; Copper; Culture Techniques; Dihydroxyphenylalanine; Hydroquinones; Melanins; Melanocyte-Stimulating Hormones; Melanoma; Melatonin; Mice; Motion Pictures; Pigmentation; Tyrosine | 1966 |
Molecular biology of pigment cells. Molecular controls in mammalian pigmentation.
Topics: Animals; Binding Sites; Catechol Oxidase; Clone Cells; Cyclic AMP; Enzyme Induction; Melanins; Melanocyte-Stimulating Hormones; Melanocytes; Melanoma; Mice; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Nucleotides; Organoids; Phenotype; Pigmentation; Tritium; Tyrosine | 1973 |
Melanin: a normal component of human eosinophils.
Topics: Adolescent; Adult; Aged; Animals; Basophils; Catecholamines; Child; Child, Preschool; Color; Dihydroxyphenylalanine; Eosinophils; Histological Techniques; Humans; Inclusion Bodies; Melanins; Melanocytes; Melanoma; Mice; Microscopy, Electron; Middle Aged; Neoplasms, Experimental; Organoids; Oxidation-Reduction; Peroxidases; Tyrosine | 1974 |
Regulation of melanocyte stimulating hormone action at the receptor level: discontinuous binding of hormone to synchronized mouse melanoma cells during the cell cycle.
Topics: Animals; Binding Sites; Catechol Oxidase; Cell Division; Cell Line; Cells, Cultured; Cyclic AMP; Iodine Radioisotopes; Melanocyte-Stimulating Hormones; Melanoma; Mice; Neoplasms, Experimental; Polysaccharides; Protein Binding; Receptors, Cell Surface; Time Factors; Tyrosine | 1974 |
Effect on growth and structure of transplantable malignant melanomas of the Syrian golden hamster (Mesocricetus auratus) by depletion of phenylalanine and tyrosine in the diet and by inhibition of tyrosinase. Brief report.
Topics: Animals; Catechol Oxidase; Copper; Cricetinae; Cytoplasmic Granules; Diet; Genitalia; Hair; Melanocytes; Melanoma; Microscopy, Electron; Neoplasm Transplantation; Penicillamine; Phenylalanine; Pigmentation; Tyrosine | 1974 |
Melanocyte function: influence of cyclic adenosine monophosphate.
Topics: Animals; Anura; Catechol Oxidase; Cyclic AMP; Humans; Larva; Melanins; Melanocyte-Stimulating Hormones; Melanocytes; Melanoma; Neoplasms, Experimental; Pigments, Biological; Receptors, Cell Surface; Tyrosine; Vinblastine | 1974 |
Reduced intake of phenylalanine and tyrosine as treatment of choroidal malignant melanoma.
Topics: Choroid Neoplasms; Dietary Proteins; Female; Humans; Melanins; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Phenylalanine; Remission, Spontaneous; Tyrosine; Ultrasonics; Vision, Ocular; Visual Fields | 1974 |
The influence of phenylalanine- and tyrosine-low diet on the growth and structure of transplantable malignant melanomas of the Syrian golden hamster (Mesocricetus auratus).
Topics: Amino Acids; Animals; Cricetinae; Cytoplasm; Dietary Proteins; Genitalia; Hair; Macrophages; Melanins; Melanocytes; Melanoma; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental; Phenylalanine; Skin; Skin Neoplasms; Transplantation, Homologous; Tyrosine | 1974 |
Melanocytic neoplasms.
Topics: Dihydroxyphenylalanine; Epinephrine; Humans; Melanins; Melanocytes; Melanoma; Mustard Compounds; Neoplasm Metastasis; Neurons; Phenylalanine; Pigments, Biological; Skin Neoplasms; Tyrosine | 1974 |
Peroxidatic oxidation of tyrosine to melanin in supernatant of crude mouse melanoma homogenates.
Topics: Animals; Electrophoresis, Polyacrylamide Gel; Melanins; Melanoma; Mice; Oxidation-Reduction; Peroxides; Spectrophotometry; Tyrosine | 1974 |
Fate of L-(3,5- 3H) tyrosine in cell-free extracts and tissue cultures of melanoma cells: a new assay method for tyrosinase in living cells.
Topics: Animals; Catechol Oxidase; Cell Line; Cell-Free System; Cells, Cultured; Chromatography, Paper; Culture Media; Dihydroxyphenylalanine; Humans; Hydroxylation; Melanins; Melanoma; Methods; Mice; Mice, Inbred Strains; Pyridines; Thiocarbamates; Tritium; Tyrosine | 1972 |
Intracellular localization of tyrosinase inhibitor in amelanotic and melanotic malignant melanoma.
Topics: Animals; Catechol Oxidase; Cricetinae; Cytoplasm; Dihydroxyphenylalanine; Golgi Apparatus; Melanins; Melanoma; Microscopy, Electron; Mitochondria; Neoplasms, Experimental; Succinate Dehydrogenase; Tyrosine | 1972 |
Effects of alpha-MSH on melanogenesis and tyrosinase of B-16 melanoma.
Topics: Animals; Catechol Oxidase; Female; Melanins; Melanocyte-Stimulating Hormones; Melanoma; Mice; Neoplasms, Experimental; Subcellular Fractions; Time Factors; Tritium; Tyrosine | 1972 |
Quantitative study of melanosome and mitochondrial populations in pigmented and amelanotic S-91 mouse melanomas.
Topics: Animals; Catechol Oxidase; Male; Melanocytes; Melanoma; Mice; Mice, Inbred DBA; Microscopy, Electron; Mitochondria; Neoplasm Transplantation; Oxygen Consumption; Tyrosine | 1973 |
[Biochemical diagnosis of pheochromocytoma, neuroblastoma and other neuro-ectodermal neoplasms].
Topics: Adolescent; Adult; Catecholamines; Child; Child, Preschool; Dihydroxyphenylalanine; Dopamine; Electrophoresis, Paper; Epinephrine; Female; Ganglioneuroma; Glycols; Histocytochemistry; Humans; Infant; Male; Melanoma; Methods; Middle Aged; Neoplasms; Nervous System Diseases; Neuroblastoma; Norepinephrine; Normetanephrine; Pheochromocytoma; Sympathetic Nervous System; Tyramine; Tyrosine; Vanilmandelic Acid | 1972 |
Subcellular demonstration of peroxidatic oxidation of tyrosine to melanin using dihydroxyfumarate as cofactor in mouse melanoma cells.
Topics: Amines; Animals; Biphenyl Compounds; Carbamates; Dihydroxyphenylalanine; Endoplasmic Reticulum; Fumarates; Golgi Apparatus; Hydrogen Peroxide; Melanins; Melanoma; Mice; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental; Oxidation-Reduction; Peroxidases; Thiocarbamates; Tyrosine | 1973 |
Anti-tumor effect of the amino acid minosine.
Topics: Alanine; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Dose-Response Relationship, Drug; Genitalia; Hair; Male; Melanoma; Neoplasms; Plant Extracts; Pyridones; Rats; Tyrosine | 1973 |
The effect of a phenylalanine-tyrosine low diet on the growth and morphology of transplantable malignant melanomas of the Syrian golden hamster (Mesocricetus auratus).
Topics: Animals; Cell Transformation, Neoplastic; Copper; Cricetinae; Diet; Hair; Melanins; Melanocytes; Melanoma; Microscopy, Electron; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Phenylalanine; Pigmentation Disorders; Protein Deficiency; Skin; Skin Neoplasms; Transplantation, Homologous; Tyrosine | 1973 |
Identification of melanoma cells by formaldehyde-induced fluorescence.
Topics: Adenocarcinoma; Cell Line; Culture Techniques; Cysteine; Dopamine; Fluorescence; Formaldehyde; HeLa Cells; Humans; Melanoma; Tyrosine; Ultraviolet Rays | 1974 |
Melanogenesis from tryptophan. Biogenetic experiments with Harding-Passey mouse melanoma.
Topics: Animals; Carbon Radioisotopes; Kynurenine; Melanins; Melanoma; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Tryptophan; Tyrosine | 1974 |
Proliferation and differentiation of pigment cells in vitro.
Topics: Animals; Carbon Isotopes; Cell Count; Cell Differentiation; Cell Division; Cell Line; Chromatophores; Clone Cells; Culture Techniques; Cycloheximide; DNA; Melanins; Melanoma; Mice; Microscopy; Microscopy, Phase-Contrast; Protein Biosynthesis; Thymidine; Tritium; Tyrosine | 1970 |
In vitro growth inhibition of S-91 mouse melanomas by tyrosinase substrate analogs with and without L-cysteine.
Topics: Animals; Catechol Oxidase; Chemical Phenomena; Chemistry; Cysteine; In Vitro Techniques; Melanoma; Mice; Neoplasms, Experimental; Phenylalanine; Tyrosine | 1967 |
Tyrosinase activity in serum from normal and melanoma-bearing mice.
Topics: Animals; Ascorbic Acid; Catechol Oxidase; Dihydroxyphenylalanine; Hot Temperature; Melanoma; Mice; Neoplasm Transplantation; Tritium; Tyrosine; Ultracentrifugation | 1968 |
Oxidation of phenolic compounds by Mycobacterium leprae and inhibition of phenolase by substrate analogues and copper chelators.
Topics: Animals; Basidiomycota; Catechol Oxidase; Chelating Agents; Copper; Humans; Melanoma; Mice; Mycobacterium; Mycobacterium leprae; Phenols; Phenylalanine; Tyrosine | 1968 |
Tyrosine release and tyrosinase activity in amelanotic and melanotic malignant melanoma.
Topics: Animals; Catechol Oxidase; Cricetinae; Kinetics; Melanins; Melanoma; Tyrosine | 1969 |
State of tyrosinase in melanoma melanosomes.
Topics: Animals; Catechol Oxidase; Lipase; Melanoma; Mice; Neoplasms, Experimental; Phospholipases; Tyrosine | 1969 |
The histochemical tyrosine-dopa reaction for tyrosinase and its use in localizing tyrosinase activity in mast cells.
Topics: Animals; Catechol Oxidase; Dihydroxyphenylalanine; Histocytochemistry; Humans; Mast Cells; Melanoma; Methods; Microscopy, Electron; Neoplasms; Pigments, Biological; Rats; Tyrosine | 1969 |
Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance.
Topics: Animals; Antimetabolites; Autoradiography; Catechol Oxidase; Cell Differentiation; Cell Division; Cell Line; Chromosomes; Clone Cells; Colchicine; Culture Media; Cytarabine; Melanins; Melanoma; Mice; Models, Biological; Pigmentation; Time Factors; Tyrosine | 1969 |
Inhibition of S-91 mouse melanoma metastases and growth by D-penicillamine.
Topics: Animals; Catechol Oxidase; Copper; Cysteine; Melanoma; Mice; Neoplasm Metastasis; Penicillamine; Tyrosine | 1969 |
Generalized melanosis secondary to malignant melanoma. Report of a case with serum and tissue tyrosinase studies.
Topics: Catechol Oxidase; Dihydroxyphenylalanine; Female; Humans; Lung Neoplasms; Melanins; Melanoma; Melanosis; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Splenic Neoplasms; Tyrosine; Vaginal Neoplasms | 1969 |
Activation of tyrosinase in microsomes and melanosomes from B16 and Harding-Passey melanomas.
Topics: Acetone; Animals; Catechol Oxidase; Chloromercuribenzoates; Chromatophores; Digitalis Glycosides; Enzyme Activation; Freezing; Iodoacetates; Melanins; Melanocytes; Melanoma; Metals; Mice; Microsomes; Mitochondria; Neoplasm Transplantation; Neoplasms, Experimental; Phospholipases; Stimulation, Chemical; Succinate Dehydrogenase; Sulfhydryl Compounds; Surface-Active Agents; Temperature; Time Factors; Tritium; Tyrosine; Vibration | 1970 |
The role of peroxidase vs. the role of tyrosinase in enzymatic conversion of tyrosine to melanin in melanocytes, mast cells and eosinophils.
Topics: Animals; Carbon Isotopes; Catechol Oxidase; Chromatophores; Dihydroxyphenylalanine; Dogs; Eosinophils; Guinea Pigs; Histocytochemistry; Humans; In Vitro Techniques; Mast Cells; Melanins; Melanocytes; Melanoma; Mice; Peroxidases; Rats; Temperature; Thiocarbamates; Tyrosine | 1970 |
Effect of phenothiazines on melanoma tyrosinase activity.
Topics: Adrenal Glands; Animals; Basidiomycota; Carbon Isotopes; Catechol Oxidase; Cell Membrane Permeability; Chlorpromazine; Detergents; Digitalis Glycosides; Dihydroxyphenylalanine; Freezing; In Vitro Techniques; Melanins; Melanoma; Mice; Mixed Function Oxygenases; Myocardium; Neoplasms, Experimental; Phenothiazines; Tyrosine | 1970 |
Regulation of tyrosinase activity in mouse melanoma and skin by changes in melanosomal membrane permeability.
Topics: Animals; Bile Acids and Salts; Catechol Oxidase; Cell Membrane Permeability; Chloroquine; Chlorpromazine; Chromatophores; Detergents; Digitalis Glycosides; Freezing; Homeostasis; Lysosomes; Melanins; Melanocytes; Melanoma; Mice; Microscopy, Electron; Neoplasms, Experimental; Peptide Hydrolases; Proteins; Skin; Skin Neoplasms; Steroids; Tritium; Tyrosine | 1971 |
[Immunologic analysis of tyrosinase in malignant melanoma, nevi and clinically normal skin].
Topics: Adolescent; Adult; Agar; Aged; Catechol Oxidase; Child; Child, Preschool; Dihydroxyphenylalanine; Electrophoresis; Female; Gels; Humans; Immune Sera; Immunodiffusion; Immunoelectrophoresis; Male; Melanoma; Middle Aged; Nevus, Pigmented; Skin; Skin Neoplasms; Tissue Extracts; Tyrosine | 1971 |
Unusual effects of reducing agents on 0-diphenoloxidase of Mycobacterium leprae.
Topics: Animals; Ascorbic Acid; Azides; Basidiomycota; Catechol Oxidase; Cell-Free System; Cyanides; Cysteine; Cystine; Dihydroxyphenylalanine; Glutathione; Humans; Manometry; Melanins; Melanoma; Mice; Mycobacterium leprae; Oxidation-Reduction; Quinones; Skin; Species Specificity; Spectrophotometry; Spleen; Stereoisomerism; Tissue Extracts; Tyrosine | 1971 |
Proteolytic activity of the homogenates of transplantable melanotic and amelanotic melanoma in golden hamster (Mesocricetus auratus, Waterhouse).
Topics: Animals; Cricetinae; Female; Hydrogen-Ion Concentration; Melanins; Melanoma; Neoplasm Metastasis; Neoplasm Regression, Spontaneous; Neoplasm Transplantation; Neoplasms, Experimental; Nitrogen; Peptide Hydrolases; Specific Gravity; Tyrosine | 1972 |
On the etiology of vitiligo and gray hair.
Topics: Addison Disease; Adult; Alopecia Areata; Anemia, Pernicious; Autoimmune Diseases; Catechols; Female; Hair; Humans; Hydroquinones; Hyperthyroidism; Male; Melanins; Melanocytes; Melanoma; Phenols; Pigmentation; Scleroderma, Localized; Tyrosine; Vitiligo | 1971 |
The tyrosine hydroxylase activity of mammalian tyrosinase.
Topics: 5-Hydroxytryptophan; Animals; Ascorbic Acid; Carbamates; Cricetinae; Cyanides; Dihydroxyphenylalanine; Enzymes; In Vitro Techniques; Melanoma; Mixed Function Oxygenases; Tritium; Tyrosine; Tyrosine Decarboxylase | 1966 |
Failure of enzyme inhibition therapy for malignant melanoma.
Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Dopamine; Enzyme Repression; Epinephrine; Humans; Male; Melanoma; Neoplasm Metastasis; Norepinephrine; Tyrosine | 1969 |
DNA, RNA, and protein synthesis of pigment cells in culture.
Topics: Animals; Autoradiography; Chromatophores; Culture Techniques; DNA; Leucine; Melanins; Melanoma; Mice; Neoplasms, Experimental; Pigmentation; Protein Biosynthesis; Puromycin; RNA; Skin; Skin Neoplasms; Thymidine; Tritium; Tyrosine; Uridine | 1970 |
[Specific cell functions of cell and tissue cultures. II. Control of melanin synthesis in cell cultures of the Harding-Passey melanoma].
Topics: Animals; Carbon Isotopes; Culture Techniques; Depression, Chemical; Dihydroxyphenylalanine; Leucine; Melanins; Melanoma; Mice; Phenylthiourea; Thymidine; Tyrosine | 1970 |
[Thermochemical explanation of hyperthermia due to malignant melanoma].
Topics: Humans; Infrared Rays; Melanins; Melanoma; Skin Neoplasms; Skin Temperature; Thermography; Tyrosine | 1971 |
Tyrosine utilization by pigmented hamster melanoma cells cultured in vitro.
Topics: Animals; Cricetinae; Culture Techniques; Melanins; Melanoma; Neoplasms, Experimental; Pigmentation; Tyrosine | 1968 |
Tyrosine hydroxylation catalyzed by mammalian tyrosinase: an improved method of assay.
Topics: Animals; Cricetinae; Dihydroxyphenylalanine; In Vitro Techniques; Kinetics; Melanoma; Neoplasms, Experimental; Pteridines; Tyrosine; Tyrosine Decarboxylase | 1964 |
Ultrastructure of S-91 mouse melanomas subjected to phenylalanine and tyrosine restriction in vivo.
Topics: Animals; Endoplasmic Reticulum; Hypoxia; Melanoma; Mice; Microscopy, Electron; Mitochondria; Neoplasms, Experimental; Tyrosine | 1966 |
Effects of low phenylalanine-tyrosine diets on S91 mouse melanomas.
Topics: Animals; Diet; Melanins; Melanoma; Mice; Neoplasms, Experimental; Phenylalanine; Sarcoma, Experimental; Tyrosine | 1966 |
Effects of reducing the phenylalanine-tyrosine intake of patients with advanced malignant melanoma.
Topics: Adult; Blood; Diet Therapy; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Phenylalanine; Skin Neoplasms; Tyrosine | 1966 |
The conversion of [3H]tyrosine to [3H]DOPA in mouse melanoma in vivo.
Topics: Animals; Asparagine; Aspartic Acid; Chromatography, Paper; Dihydroxyphenylalanine; Electrophoresis; Glutamates; Glutamine; Melanoma; Mice; Neoplasms, Experimental; Tyrosine | 1966 |
[On the excretion of homovanillic acid in urine in malignant melanoma].
Topics: Chromatography, Paper; Humans; Melanoma; Phenylacetates; Tyrosine | 1966 |